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INTRODUCTION 
Growth may be defined as an increase in cell size (hypertrophy) or 
an increase in cell number (hyperplasia). Early in life when an animal is 
rapidly growing and increasing in size, growth occurs by hyperplasia and 
hypertrophy. After birth, growth results primarily from hypertrophy and 
continual renewal of cells in some tissues. Factors such as diet, 
environment, genetics, age and sex influence animal growth. Various 
growth factors and hormones have been identified that are involved in 
regulating the growth processes of the animal. 
The techniques currently used in animal science to study growth are 
vastly more complex than those used fifty years ago. At one time, the way 
to evaluate a nutrient or drug was to measure the animal response as an 
increase or decrease in weight. Now, there exists the capability to 
measure the response at the cellular or subcellular level rather than the 
entire animal. 
Most studies of cell growth have involved human or rodent derived 
cells with very little research being done with cells from farm animals. 
Fibroblasts are relatively easy to grow and maintain in culture 
conditions. The response of these undifferentiated cells to serum, growth 
factors and hormones may be measured as a change in DNA or protein 
synthesis. Cells become quiescent in a serum-free medium, deficient of 
growth factors. Quiescent cells can be stimulated to grow by the addition 
of serum or growth factors to the medium. 
The objectives of this work were to develop a technique for 
collecting skin tissue from farm animals; to demonstrate bovine 
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fibroblasts respond to serum, hormones and growth factors; and to evaluate 
the growth potential of bovine and porcine fibroblasts in culture as an 
indicator of animal growth. These objectives were accomplished by 
collecting skin tissue; growing fibroblasts; supplying various amounts of 
serum, hormones and growth factors to these cultured fibroblasts; and 
measuring the uptake of radiolabeled leucine, as an indicator of protein 
synthesis, and uptake of radiolabeled thymidine, as an indicator of DNA 
synthesis. To evaluate the use of cell culture as an indicator of animal 
growth, expiants were cultured from cattle and pigs. Cell growth was 
measured as thymidine incorporation, leucine incorporation and measurement 
of cell outgrowth from the expiant. Cell growth was compared to animal 
weights at various ages. 
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REVIEW OF LITERATURE 
Cell Culture 
Cell culture was first described at the turn of this century 
(Harrison, 1907). Cell culture provides a relatively.homogenous population 
that may be used to study a wide variety of effects in a controlled 
environment (pH, temperature, osmotic pressure, etc.). 
Fibroblasts are nontransformed, undifferentiated cells that are 
easily grown and propagated in culture. Proliferative ability of 
fibroblasts is dependent on age, tissue source and species. While 
studying the longevity of skin fibroblasts from 100 donors, the number of 
cell doublings significantly decreased as donor age increased (Martin et 
al., 1970). Others have reported similar findings, that is, skin 
fibroblasts from young donors generally have a longer life span than those 
from older donors (Wharton, 1984; Rosner and Cristofalo, 1979). 
The tissue source of the fibroblasts is also important. The 
replication rates of fibroblasts derived from skin and lungs of human 
fetuses were different, lung cultures grew more rapidly and had longer 
lifespans than skin cultures (Schneider et al., 1977). 
Satellite cells are undifferentiated cells found in muscle that have 
also been studied in culture systems. Satellite cells are responsible for 
repair and growth in postnatal muscle and are the primary supplier of 
muscle fiber nuclei postnatally (Allen et al., 1979). Satellite cells from 
old rats initiate DNA synthesis at a slower rate than cells from young or 
fetal rats and cells from older animals form smaller colonies than cells 
from younger animals (Schultz and Lipton, 1982). There is a relationship 
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between growth rate of turkeys and the ability of their serum to promote 
growth of cultured satellite cells (Doumit et al., 1990). Serum from 
faster growing birds was more stimulatory to satellite cells than serum 
from slower growing birds. An age related decline was seen with hen serum 
but not with tom serum. Satellite cells from 15 week old tom turkeys 
increased relative cell number (ratio of nuclei to start of the experiment) 
more than did cells from younger males. 
Cell cultures have been used to examine the effects of food 
deprivation on the ability of serum from fasted pigs to promote cell growth 
(White et al., 1988). Sera were collected from crossbred barrows before 
and after a five day fast. Addition of 2% serum from fasted animals to the 
medium decreased mitogenic activity of L6 myoblasts and the decrease varied 
from pig to pig, with individual pigs responding differently to the stress 
of fasting. This decrease was believed due to the presence of an 
unidentified inhibitor, since fasted serum inhibited proliferation in the 
presence of five percent sera from nonfasted pigs. Addition of serum 
collected after feeding was resumed, increased mitogenic activity of L6 
myoblasts. 
Growth factors and hormones have been identified as being involved in 
regulating growth of animals as well as cells in culture. Most of the 
research examining fibroblast growth has centered on the use of cells from 
human or rodent origin. These actively multiplying cells move repeatedly 
through a cell cycle consisting of four stages: 1) mitosis (M), 2) Gj 
("gap" between mitosis and DNA synthesis), 3) synthesis of DNA (S) and 4) 
^2 ("gap" between DNA synthesis and mitosis). A variety of environmental 
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conditions can cause cells to become quiescent. This Gj-like state is 
typically designated Gg (Ham, 1981). 
Maintenance and growth of cells, with growth implying an increase in 
total mass and volume (hypertrophy) along with an increase in cell number 
(hyperplasia), necessitates the presence of proper nutrients, growth 
factors, and hormones to meet the requirements of cells. "Nutrients" refer 
to chemical substances that are taken into the cell and utilized in 
biosynthesis, energy metabolism or act as catalysts in these processes. 
"Growth factors" historically are used to refer to any chemical substances 
that promote cellular multiplication. In current usage, growth factors are 
non-nutritive substances that control proliferation of cells by interacting 
with specific cellular receptors. "Hormones" classically are defined as 
chemical substances produced in one area of the body and transported in the 
blood to another target location for their effect. "Growth requirement" 
refers to virtually anything that has a positive effect on cellular 
multiplication (Ham, 1981). Thus, animal cell cultures require the 
addition of nutrients, growth factors and hormones to the culture medium to 
allow progression through the cell cycle. 
Serum is a very complex mixture, which has traditionally been used to 
provide these growth factors, hormones and nutrients. Serum is included 
during culture to supply the growth requirement needs of cells. More 
complex media have been developed to allow the survival of cells without 
serum by supplementing specific compounds, such as growth factors and 
hormones, to the medium. Much work has centered on the identification of 
growth promoting activities of various compounds, including peptides and 
steroids. 
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Peptides 
Peptides may be growth factors, which possess stimulatory actions on 
the proliferation of cells by affecting cell growth and differentiation. 
Peptides may be hormones, examples include growth hormone (GH) and insulin. 
Thyroxine, although not a peptide, is an amino acid derivative and is 
discussed with the peptide hormones. Hormones are involved in regulating 
growth of the animal. 
Growth Factors 
Growth factors are classed as either competence or progression 
factors on their ability to affect the cell cycle. Platelet-derived growth 
factor (PDGF) and fibroblast growth factor (FGF) act as competence factors 
to allow quiescent cells to enter the cell cycle in the presence of plasma-
derived factors (O'Keefe and Pledger, 1983). Progression factors, such as 
epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I), 
allow cells to traverse the cell cycle. 
Epidermal Growth Factor EGF was first isolated from mouse 
mandibular glands by Cohen (1962). It was later determined that 
urogastrone, a protein found in urine of pregnant women, and EGF were the 
same compound (Gregory, 1975). EGF is synthesized as a precursor of 1217 
amino acids with repeating amino acid sequences. The active EGF is a 
single polypeptide chain consisting of 53 amino acids with a molecular 
weight of approximately 6000 (Cohen, 1962; Scott et al., 1983; Gray et al., 
1983). 
EGF has i n  v ivo  and i n  v i t ro  biological actions. EGF stimulates the 
proliferation of epidermal and epithelial tissue in animals. Injection of 
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EGF into newborn mice results in earlier tooth eruption and eyelid opening 
than nontreated mice (Cohen, 1962). EGF stimulates proliferation of 
fibroblasts, keratinocytes and epithelial cells. EGF presence is required 
for approximately 8 hours to generate a mitogenic signal in cells 
maintained under culture conditions (Waterfield, 1989). In a mouse 
keratinocyte cell line dependent on EGF for growth, an increase in DNA 
synthesis occurred 6 hours after the addition of EGF, with maximal 
stimulation of DNA synthesis occurring approximately 20 hours after EGF 
addition (Zendegui et al., 1988). The results of adding EGF to a variety 
of cells from various species were reviewed with a slightly longer exposure 
time of 10 to 12 hours necessary to initiate DNA synthesis (Carpenter and 
Cohen, 1979). Similarly, EGF stimulated DNA synthesis in quiescent human 
fibroblasts eleven hours after addition (Westermark and Heldin, 1985). 
Varying amounts of EGF have been reported to produce a response in 
cultured cells. EGF increased thymidine incorporation in density-arrested 
EL2 rat fibroblasts with peak stimulation occurring at 2 ng/mL in the 
presence of bovine serum albumin and transferrin (Liboi et al., 1987). EGF 
alone, however, did not enhance thymidine incorporation. In human foreskin 
fibroblasts, the addition of EGF (10 ng/mL) increased cell density 212% as 
compared with control cells (Kohase et al., 1987). Ten ng/mL EGF addition 
resulted in the greatest thymidine incorporation in mouse embryo 
fibroblasts (Mulder and Childress-Fields, 1990) and 5 ng/mL gave the 
greatest incorporation of thymidine by mouse keratinocytes (Ristow and 
Messmer, 1988). EGF in serum-free or serum containing medium was mitogenic 
for human skin cells (Hosokawa et al., 1986). However, adding EGF to 
cultures of fibroblasts from numerous adult humans gave inconsistent 
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responses to EGF: cells from some donors increased thymidine uptake, cells 
from other donors decreased thymidine uptake and cells from different 
donors were unresponsive to EGF treatment (Lechner et al., 1989). The 
variation among individuals was not correlated with donor age or sex. 
An additive effect of EGF with other growth factors and hormones may 
occur. The combination of EGF and IGF-I resulted in greater thymidine 
incorporation than did either growth factor alone in quiescent mouse 
fibroblasts (Ristow and Messmer, 1988). The effects of insulin were 
additive with EGF for stimulating cell proliferation of human fibroblasts, 
but the combination was not as effective as the addition of five percent 
serum (Shipley et al., 1989). 
Protein synthesis of cultured cells can be affected by EGF addition. 
Chick embryo epidermal expiants subjected to EGF treatment had greater 
lysine uptake during 48 hours of culture compared with cells not exposed to 
EGF (Hoober and Cohen, 1967). 
Insulin-like Growth Factors In 1957, rat serum was reported to 
stimulate incorporation of into incubated rat cartilage and serum from 
hypophysectomized rats lacked this activity (Salmon and Daughaday, 1957). 
Plasma was shown to stimulate cartilage sulfation because of the presence 
of nonsuppressible insulin-like activity (NSILA; Hall and Uthne, 1972). 
Highly purified NSILA stimulated sulfate and thymidine incorporation into 
cartilage. Mitosis was stimulated in chick embryo fibroblasts maintained 
in serum-free medium for 48 hours by NSILA addition (Morell and Froesch, 
1973; Zapf et al., 1978b). Two peptides, NSILA-I and NSILA-II, were 
isolated and shown to have growth promoting action in cartilage and 
produced insulin-like effects (Rinderknecht and Humbel, 1976). These 
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peptides were renamed, insulin-like growth factor-I (IGF-I) and -II (IGF-
II), because of these insulin-like effects (Rinderknecht and Humbel, 1978). 
These polypeptides, which are evolutionarily related to proinsulin, 
have been called various names, such as, "sulfation factor" (Salmon and 
Daughaday, 1957), "somatomedins" (Daughaday et al., 1972) and insulin-like 
growth factors (Rinderknecht and Humbel, 1978). 
Somatomedin A and C and IGF-I have the same chemical structure 
(Svoboda et al., 1980; Klapper et al., 1983; Engberg et al., 1984). IGF-I 
is a basic peptide composed of seventy amino acid residues with a molecular 
weight of 7649 (Rinderknecht and Humbel, 1978). Use of the term, 
somatomedin has decreased because it implied GH regulation. IGF-I is 
regulated by GH but IGF-II is not (Baxter, 1986; Hall and Sara, 1983). In 
1987, it was recommended that the term IGF replace somatomedin (Daughaday 
et al., 1987). 
The liver is the major source of circulating IGF-I, but many other 
tissues possess the capability to synthesize IGF-I (D'Ercole et al., 1984). 
In humans, IGF-I plasma concentrations are low at birth (Gluckman et al., 
1983), rise throughout childhood, increase markedly at puberty and decline 
post-puberty (Hall and Sara, 1984; Zapf et al., 1981a; and Zapf et al., 
1981b). A similar pattern of IGF-I concentrations in plasma is seen in 
beef cattle (Plouzek and Trenkle, 1991b). 
Both IGF-I and IGF-II circulate in the blood bound to large molecular 
weight binding proteins (BPs; Clemmons and Van Wyk, 1981c; Hintz, 1984; 
Hintz and Liu, 1977; Van Wyk and Underwood, 1978). Unbound IGF is not 
found in the blood in significant amounts. The BPs may be involved in 
regulation of binding of IGFs to cell surface receptors (Baxter and Martin, 
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1989) or the circulating IGF-I/IGF BPs may provide a storage reservoir and 
prevent rapid fluctuations in concentrations found circulating in the blood 
(Zapf et al., 1978a; Zapf et al, 1984; Daughaday, 1982). Originally, it 
was believed there were two IGF BP regulating the concentrations of free 
IGFs. Currently, three distinct BP (IGFBP-1, IGFBP-2, and IGFBP-3) have 
been fully identified with amino acid sequences determined. The report 
from the IGFBP workshop held in Vancouver, Canada, (June, 1989) proposed 
the adoption of specific nomenclature for the various IGFBPs, using a 
letter prefix to designate species specificity for that IGFBP (Ballard et 
al., 1990). 
The presence of serum binding proteins is unusual for a peptide 
hormone. The lack of BP help to explain why 1 to 50 ng/mL of IGF-I in 
culture conditions is sufficient to stimulate biological activity (Zapf et 
al., 1981b), whereas, total serum concentrations of IGF-I range from 100 to 
1000 ng/mL. Acute IGF administration does not mimic the normal 
physiological condition because of a marked increase in free IGF in 
circulation which is unusual in the animal. The plasma half-life of IGF is 
estimated to be approximately twenty-four hours when bound to BPs (Sara and 
Hall, 1990), but, free IGF has a half-life of approximately ten minutes 
(Zapf et al., 1981a) which is similar to insulin (Sara and Hall, 1990). 
Insulin-like growth factors interact with cell surface receptors. 
Early work indicated IGF-I competed with insulin for receptor sites on 
isolated adipocytes, liver membranes and chondrocytes (Hintz et al., 1972; 
Marshall et al., 1974; and Zapf et al., 1978b). It was believed that the 
IGF receptor mediated the growth promoting action of IGF and insulin 
(Nissley et al., 1977), while the metabolic effects of IGF and insulin were 
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controlled by the insulin receptor (King et al., 1980; Van Wyk and 
Underwood, 1978). Later work has shown insulin stimulates growth via the 
insulin receptor and IGF stimulates glucose transport via the IGF receptor 
(Nissley and Rechler, 1984). Competitive binding studies examining IGF 
receptors have identified at least two types of IGF receptors: 1) type I 
receptors which bind IGF-I better than IGF-II with insulin having limited 
binding and 2) type II receptors which bind IGF-II better than IGF-I and no 
binding of insulin. There is limited ability of IGF-I and IGF-II to bind 
to the insulin receptor (Daughaday, 1982; Daughaday et al., 1981). The 
affinity of the insulin receptor for IGFs is approximately one hundred 
times lower than for insulin (Steele-Perkins et al., 1988). Insulin at 
supraphysiological concentrations (1 fig/ml) has been shown to bind to the 
IGF-I receptor (Van Wyk and Underwood, 1978). The type I IGF receptor has 
considerable sequence homology with the insulin receptor which allows 
insulin, when present in high concentrations, to bind to this receptor 
(Massague and Czech, 1982). There are differences in receptor affinity and 
receptor number for IGF-I in human skin derived fibroblasts (Clemmons et 
al., 1986). Cells from fetal-newborn donors had greater receptor affinity 
for IGF-I than did cells from either juveniles (3-14 years) or older 
persons (72-96 years), when grown at low culture densities. Increasing 
culture density decreased the receptor affinity for IGF-I in the newborns 
and juveniles. There was no change in receptor affinity at high or low 
cell density for cells from older persons. Cells from fetal donors 
possessed the lowest concentrations of receptors at low densities. The 
fetal-newborn group did not exhibit differences in receptor number in 
response to differing cell densities. High density culture conditions 
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reduced the receptor concentrations on cells from juveniles and older 
persons. 
IGF-I can stimulate synthesis of nucleic acids and cell replication 
in primary chick embryo fibroblasts (Zapf et al., 1978b) and in human 
fibroblasts (Rechler et al., 1974). However, in these experiments, IGF-I 
was not as good as serum for stimulating cells. IGF-I stimulated satellite 
cell proliferation in serum-free medium (Allen and Rankin, 1990). Human 
IGF-I or porcine insulin stimulated the rate of DNA synthesis in chick 
satellite cells grown in medium containing .02% serum (Duclos et al., 
1991). Maximal IGF-I response occurred at 50 ng/mL and a 1000 fold higher 
insulin amount was required to produce a similar effect. The insulin 
response resulted from binding to the type-I IGF receptor. The combination 
of insulin with IGF-I was not additive, supporting the theory that a single 
type of receptor was involved. IGF-I was weakly mitogenic for fibroblasts 
from adult humans grown in monolayers without serum (Conover et al., 1983). 
Human hypopituitary serum was not mitogenic. Combining IGF-I with .5% 
human hypopituitary serum (HHS) dramatically increased thymidine 
incorporation over IGF-I or serum alone. Dexamethasone added with IGF-I in 
the presence of .5% HHS increased number of fibroblast cells more than any 
of these compounds alone (Rosenfeld et al., 1984). IGF-I with .5% HHS 
increased thymidine incorporation 107% and cell replication 169% in human 
fibroblasts, as compared with cells grown in serum-free medium (Cook et 
al., 1988). IGF-I induced DNA synthesis, as measured by thymidine 
incorporation, in PDGF primed competent Balb/c 3T3 cells but not in 
quiescent cells (Kojima, 1990). 
The effect of passage (dispersal of cells resulting from enzymatic 
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treatment or dilution for purposes of subculturing) number on binding of 
IGF-I has been examined (Conover et al., 1987a). IGF-I treatment in early 
(6-15 passage) and late passage (36-42 passage) human cells resulted in 
equivalent stimulation of thymidine incorporation. 
IGF-I stimulated leucine incorporation in chick embryo fibroblasts 
(Zapf et al., 1981a) and in human fibroblasts (Conover et al., 1985a). 
Hormones 
Certain hormones have been shown to regulate growth of skeletal and 
soft tissues. These hormones react with receptors to cause growth 
stimulation and there are interactions between hormones. 
Growth hormone Both human and bovine GH are 191 amino acid single 
chain polypeptides containing two intrachain disulfide bridges (Butt, 
1975). It was proposed that the growth promoting activity of GH was 
mediated through the actions of the insulin-like growth factors (Salmon and 
Daughaday, 1957). 
GH has both i n  v ivo  and i n  v i t ro  activity. Feedlot steers receiving 
intramuscular injections of growth hormone have increased average daily 
gain and improved feed efficiency (Moseley et al., 1990). Fat content is 
reduced and protein content is increased in the carcass. Bulls and steers 
had highest IGF-I concentrations as compared with intact and ovariectomized 
heifers at 12 to 15 months of age (Plouzek and Trenkle 1991b) and also 
exhibited the highest average daily gain (Plouzek and Trenkle, 1991a). GH 
was higher in males than females. GH and insulin have been implicated in 
the production of IGF-I in cattle (Plouzek and Trenkle, 1991b). 
GH stimulated human fibroblasts to undergo DNA synthesis in the 
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presence of platelet-poor plasma from a hypopituitary individual (Clemmons 
and Van Wyk, 1981b). GH has been shown to stimulate production of IGF-I in 
cultures of human skin and lung derived fibroblasts (Atkison et al., 1980; 
Clemmons et al., 1981a) and in rat fibroblasts from twenty-five day old 
rats but not from fetal rats (Adams et al., 1983). 
The addition of GH (10 or 100 ng/mL) to serum-free medium did not 
alter thymidine incorporation of human fibroblasts (Cook et al., 1988). 
However, the addition of GH (10 ng/mL) with .5% human hypopituitary serum 
increased thymidine incorporation 127% and cell replication 172% compared 
with serum-free medium. 
Insulin Insulin has a molecular weight of 5734 and contains two 
chains, A (21 amino acids) and B (30 amino acids), which are linked through 
disulfide bonds (Guyton, 1968). Insulin has many functions, it enhances 
glucose metabolism, decreases blood glucose level, increases glycogen 
storage, and has a protein sparing effect in the animal. 
The effects of insulin on growth have been studied in many types of 
cells, such as chick embryo fibroblasts (Temin, 1967; Temin, 1968), human 
fibroblasts (Hollenberg and Cuatrecasas, 1975), mouse 3T3 fibroblasts (De 
Asua et al., 1977a; De Asua et al., 1977b), rat liver cells (Leffert, 1974) 
and baby hamster kidney cells (De Asua et al., 1973). 
In human breast cancer cells, insulin is a more potent mitogen than 
estradiol or EGF (Van der Burg et al., 1988). Using a combination of 
insulin with estradiol resulted in greater cellular proliferation than 
either hormone separately. 
Insulin at levels from 10 to 100 /xg/mL resulted in equal stimulation 
of thymidine incorporation by mouse embryo fibroblasts (Mulder and 
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Childress-Fields, 1990). However, response to insulin was not as great as 
seen from optimal concentrations of serum (Hollenberg and Cuatrecasas, 
1975; De Asua et al., 1977a; De Asua et al., 1977b; Leffert, 1974). 
Insulin in supraphysiological concentrations (10 ng/ml )  enhanced 
epithelial cell proliferation in a small intestinal crypt cell line 
(Conteas et al., 1989). The presence of insulin with EGF increased the 
amount of EGF required to produce a proliferative response from 2 to 50 
ng/mL. 
Insulin addition increased incorporation of leucine into protein in 
chick embryo fibroblasts (Zapf et al., 1981a). Human fibroblasts also had 
increased leucine incorporation due to the presence of insulin in the 
serum-free medium (Conover et al., 1985a). 
Thyroid hormones Thyroxine (T4) is an iodinated derivative of 
tyrosine and regulates metabolic processes in the animal. Triiodothyronine 
(T3) has three atoms of iodine rather than four found in T^. The effects 
of T4 on animal growth have been well demonstrated. There is a highly 
significant curvilinear correlation between thyroid activity and growth 
rate in lambs, with growth being depressed in hypo- and hyper-thyroid lambs 
(Draper et al., 1968). 
Female dwarf mice with pituitary glands that secreted very low 
amounts of GH, prolactin and thyroid stimulating hormone when injected with 
bovine GH and/or T3, exhibited increased weight gain, tail length and liver 
cell size as compared with injection of saline (Fouchereau-Peron et al., 
1981). The greatest response in tail length resulted from the combination 
of hormones; however, this was not statistically different from the two 
individual hormones. Dwarf mice given human GH and T4 had increased 
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sulfate and thymidine incorporation into costal cartilage (Van Buul and Van 
den Brande, 1978). This was an additive response for the two hormones. 
The effect was age-dependent with greater incorporation seen in younger 
animals. 
Hypopituitary dwarf mice have lower IGF serum levels than normal mice 
(Holder and Wall is, 1977). Treatment of dwarf mice with bovine GH or T* 
increased serum IGF level (primarily IGF-I) and increased growth. In 
neonatal and juvenile hypophysectomized rats, the combination of GH and T4 
restored growth to normal (Glasscock et al., 1991). T4 replacement in the 
neonatal rat restored IGFBP-2 to normal levels. GH alone was effective in 
restoring IGF-I and -II to control values. 
In cultured mice fibroblasts, T^ bound to plasma membrane receptors 
with one-third the affinity of T3 (Cheng, 1983). Cultured human kidney 
epithelial cells treated with T3 and T^ had increased thymidine uptake 
(Siegel and Tobias, 1966). T4 stimulated an increase in cell number, 
whereas, T3 stimulated protein synthesis and increased the number of 
nucleoli within the nucleus. 
Thyroid hormones have been implicated in regulating EGF production 
(Hoath et al., 1983). Treatment of mice pups with T3 elevated EGF levels, 
as measured by radioimmunoassay in neonatal skin and mandibular glands as 
compared with untreated pups. Cultured porcine aortic smooth muscle cells 
did not increase cellular replication following T4 administration in serum-
free medium or in medium containing platelet poor plasma supplemented with 
IGF-I following exposure to platelet derived growth factor (Clemmons, 
1984). 
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Steroids 
Steroid hormones contain the cyclopentanoperhydrophenanthrene nucleus 
and are classed on the basis of their effects. Examples of steroids 
include the glucocorticoids (such as hydrocortisone and dexamethasone), the 
mineralocorticoids (aldosterone) and the sex hormones (estrogen, 
progesterone and testosterone). 
Glucocorticoids 
Mixed results have been reported from the addition of 
glucocorticoids to cell cultures. Addition of hydrocortisone decreased DNA 
synthesis in chick embryo fibroblasts, but not in virus-transformed cells 
(Fodge and Rubin, 1975). Opposite results were observed in fetal lung 
fibroblasts, hydrocortisone consistently stimulated the growth of normal 
fetal lung fibroblasts and inhibited virus-transformed cells (Rosner and 
Cristofalo, 1979). Hydrocortisone increased cell proliferation in four 
lines of human fibroblasts derived from fetal lung and inhibited 
proliferation of one line (Kondo et al., 1985). Hydrocortisone stimulated 
cell proliferation in four lines of human skin fibroblasts and inhibited 
one cell line. There was no age dependent response to hydrocortisone by 
human skin fibroblasts, with age of donors ranging from 21 to 77 years. In 
contrast, earlier work had indicated fetal skin cultures were inhibited by 
glucocorticoid treatment; whereas, those from older donors reacted 
differently: five were stimulated, two were inhibited and four were 
unresponsive (Rosner and Cristofalo, 1979). 
DNA synthesis was unaffected by hydrocortisone and insulin addition 
in early and late passage human fibroblasts (Germinario and McQuillan, 
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1985). These early and late passage cells were obtained from both young 
(average 20 years) and old (average 74 years) individuals. 
An inhibition of amino acid incorporation was observed in rat and 
chick embryo fibroblasts from glucocorticoid addition (Murota et al., 1976; 
Baseman and Hayes, 1975). Others have seen a pronounced stimulation of 
amino acid uptake from glucocorticoid addition (Russell et al., 1982). 
Dexamethasone stimulated the uptake of a-aminoisobutyric acid, an amino 
acid analog, in cultured human skin fibroblasts (Hollenberg, 1977). 
Preincubating cells with dexamethasone, prior to growth factor addition was 
beneficial (Kaplowitz, 1987). Human fibroblasts derived from donors of 
various ages, pretreated with dexamethasone, increased uptake of a-
aminoisobutyric acid and thymidine following IGF-I addition. 
The growth promoting action of EGF was amplified by dexamethasone; 
whereas, dexamethasone alone did not increase human fibroblast density 
(Kohase et al., 1987). Dexamethasone enhanced the mitogenic action of EGF 
in human skin cells by approximately 50% (Baker et al., 1978). Mouse 
keratinocyte growth was inhibited by the presence of dexamethasone added 
with EGF (Zendegui et al., 1988). 
Thymidine incorporation was enhanced by dexamethasone in human 
fibroblasts treated with IGF-I (Conover et al., 1985b) or growth hormone 
(Cook et al., 1988). Peak thymidine incorporation occurred 22 to 28 hours 
after IGF-I and dexamethasone addition (Conover et al., 1987a). 
Preincubation of dexamethasone with IGF-I gave a varied response between 
early and late passage human fibroblasts. Dexamethasone with IGF-I 
increased thymidine incorporation in early passage human fibroblasts 
(Conover et al., 1983; Conover et al., 1986; Conover et al., 1987a), 
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whereas, addition of dexamethasone to late passage cells did not enhance 
the effects of IGF-I (Conover et al., 1987a). Human lung fibroblasts also 
became less responsive to dexamethasone in the presence of insulin or EGF 
with increased age (Phillips et al., 1984). 
Estrogen 
Growth of rodents and cattle is affected by estrogen in different 
ways. Exogenous estrogen decreased the growth rate of rats (Heywood and 
Wadsworth, 1980). In mice, exposure to 640 ppb dietary estrogen for longer 
than ten weeks resulted in decreased body weights (Greenman and 
Delongchamp, 1979), whereas, a single subcutaneous injection of 2 mg/kg 
body weight estradiol (E^) caused a significant increase in weight, cell 
count and protein and DNA content of liver in mice during a seven day 
experiment (Schwarzlose and Heim, 1970). 
Exogenous estrogens improve weight gains of cattle (Burroughs et al., 
1954; Brier et al., 1988). Cattle exhibit increased liver weight from 
exogenous estrogen treatment (Preston, 1975). The weight of the anterior 
pituitary, total amount of GH per animal and plasma insulin concentrations 
were also increased by exogenous estrogen administration (Trenkle and 
Burroughs, 1967). Steers treated with E2 implants had increased IGF-I 
levels as compared with nonimplanted steers (Brier et al., 1988). 
E2 alone was slightly mitogenic in human breast cancer cells (Van der 
Burg et al., 1988). These cells were grown in medium containing 
inactivated fetal bovine serum. However, E2 (10'^ M) with insulin (10 or 
100 ng/mL) stimulated thymidine incorporation more than insulin alone. 
This response was not seen at high insulin concentrations, only suboptimal 
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insulin concentrations required the presence of Eg. IGF-I production may 
be induced by the presence of estrogen in human breast cancer cells (as 
reviewed by Dickson and Lippman, 1987). 
Estrogen administration did not stimulate mitogenesis in chick embryo 
cells in serum-free medium supplemented with insulin (Baker et al., 1979). 
Similarly, the addition of Eg with IGF-I and .5% human hypopituitary serum 
did not increase thymidine incorporation in adult human fibroblasts 
(Conover et al., 1983). 
Testosterone 
In steers or bulls, trenbolone acetate (TBA), a testosterone analog, 
did not increase average daily gain (Hunt et al., 1991). However, TBA with 
estrogen increased gain and feed intake in steers but not in bulls during 
the growing phase. Steers receiving a combination of TBA and estrogen had 
increased serum IGF-I levels as compared with nonimplanted controls. 
Serum from rats treated with TBA, stimulated greater satellite cell 
proliferation than serum from untreated rats (Thompson et al., 1989). 
Satellite cells from TBA-treated rats were more responsive to IGF-I than 
cells from untreated rats. However, direct addition of TBA to cultured 
satellite cells had no effect on proliferation. 
Testosterone did not have any mitogenic stimulation of chick embryo 
cells (Baker et al., 1979). Testosterone in the presence of IGF-I and .5% 
human hypopituitary serum did not increase thymidine incorporation as 
compared to IGF-I and human hypopituitary serum for adult human fibroblasts 
(Conover et al., 1983). Testosterone did not stimulate the uptake of the 
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amino acid analog, a-aminoisobutyric acid in human skin-derived fibroblasts 
(Hollenberg, 1977). 
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SECTION I. 
CULTURE OF BOVINE FIBROBLASTS AND 
THEIR RESPONSE TO SERUM AND HORMONES 
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INTRODUCTION 
Fibroblasts are undifferentiated cells that are easily maintained 
and propagated in culture. Cells from one individual may be used in 
numerous experiments. Most research has centered on the use of human 
(Conover et al., 1987a; Conover et al., 1987b; Conover et al., 1989; Chen 
and Rabinovitch, 1990a; Chen and Rabinovitch, 1990b; Colige et al., 1990) 
and rodent-derived (Liboi et al., 1987) cells. Human samples are normally 
collected from the forearm (Cooper and Goldstein, 1973), the inner area of 
the upper arm (Sly and Grubb, 1979) or from genital skin (Griffin et al., 
1976). Because of hair coat, size of animals and limited accessibility to 
different parts of the body, samples of skin are not easily obtained from 
cattle. 
One objective of this research was to develop a culture system for 
bovine fibroblasts. A method is described for obtaining skin biopsies and 
propagating fibroblasts from the ears of cattle. A second objective was to 
study the effects of hormones on growth of bovine fibroblasts because 
cattle seem to respond differently to exogenous estrogen than do rodents 
(Brier et al., 1988; Heywood and Wadsworth, 1980). 
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MATERIALS AND METHODS 
Obtaining a Skin Biopsy 
Materials 
Ear notcher, normally used for identifying baby pigs or calves 
Sterile ICQ mL glass bottle containing approximately 25 mL transport 
medium 
Methods 
The lower portion of the bovine ear was selected for the biopsy site, 
with various sizes of animals sampled. The ear notcher cut a triangular 
tissue sample approximately .5x.5x.5 cm in size. The tissue sample was 
dropped into a sterile 100 mL screw capped glass bottle containing 25 mL 
transport medium made up of Ham's F-12 medium (Sigma Chemical Co., St. 
Louis, MO), prepared according to instructions, and contained 10% fetal 
bovine serum (FBS; Gibco Laboratories, Grand Island, NY), 3x10^ U/L 
penicillin (Sigma Chemical Co., St. Louis, MO), 300 mg/L streptomycin 
sulfate (Sigma Chemical Co., St. Louis, MO) and 2.4x10^ U/L nystatin (Sigma 
Chemical Co., St. Louis, MO). Tissue sections were plated upon return to 
the laboratory or within twenty-four hours. When subsampling at a later 
time, the bottle containing sample was placed in a 4 C refrigerator until 
time of plating. 
Establishment of the Cell Strain 
Materials 
60 mm sterile petri dish (Nunc, Roskilde, Denmark) 
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Stadie-Riggs Microtome (Thomas Scientific, Swedesboro, NJ) 
100 mm sterile petri dish (Nunc, Roskilde, Denmark) 
Scalpel with No. 10 blade, sterilized 
Flat-tipped forceps, sterilized 
Mouse-tooth forceps, sterilized 
Plastic pipette tip (Rainin Instrument Co., Inc., Woburn, MA), 
sterilized 
18 mm round cover slips. No. 1 thickness (Fisher Scientific Co., 
Chicago, IL), sterilized 
High vacuum grease (Dow Corning, Midland, MI), sterilized 
70% alcohol 
Ham's F-12 medium, containing 10% FBS, 1x10® U/L penicillin, 100 mg/L 
streptomycin sulfate and 2.4x10® U/L nystatin. Medium was 
prepared according to Sigma instructions with the addition of 
FBS and antimicrobials. 
Alcohol soaked cloth 
Glass 5 mL pipette (Fisher Scientific Co., Chicago, IL) 
Container for waste medium 
Methods 
The "plating" of a tissue biopsy sample was performed in a laminar-
flow hood to prevent bacterial contamination of the culture. The aim was 
to slice the sample into small pieces to allow outgrowth of fibroblasts. 
The medium and sample of tissue were poured from the glass bottle 
into a sterile 100 mm petri dish. With flat-tipped forceps the sample was 
placed on the base of the microtome rinsed with 70% alcohol. The epidermis 
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was sliced off and discarded. The remaining tissue was turned over and the 
other epidermal layer was removed and discarded. The remaining dermal 
sample was sliced to yield a tissue layer approximately .5 mm thick. 
Depending on the thickness of the remaining tissue, other slices of tissue 
were cut. Flat-tipped forceps rinsed in alcohol were used to gently place 
.5 mm layer of tissue in the sterile lid of the 100 mm petri dish. The 
scalpel, rinsed in alcohol, was used to cut 1 x 1 mm squares of tissue (.5 
mm thick). 
One piece of tissue was transferred on the scalpel blade tip to three 
dry 60 mm sterile petri dishes, two other pieces of tissue were placed 
within a semi-circular area to fit underneath a circular glass coverslip. 
A sterile plastic pipette tip was used to place a spot of sterile high 
vacuum silicone grease on the petri dish, near the tissue pieces. Mouse-
toothed forceps were used to place a glass coverslip over the tissue pieces 
and silicone grease. The coverslip was gently pressed down onto the tissue 
pieces and silicone grease. The tissue pieces were located near the edge 
of the coverslip. The coverslip was used to hold the tissue pieces in 
place to allow outgrowth of cells. A small amount of medium was added near 
the edge of the coverslip using a sterile pipette. The medium flowed 
underneath the coverslip by capillary action. The remainder of the 5 mL of 
medium was added directly on top of the coverslip. Air bubbles were not 
allowed to remain underneath the coverslip. A permanent marker was used to 
label the dish with appropriate information, such as animal identification 
number and date. 
The dishes were placed in a humidified, 5% carbon dioxide atmosphere 
incubator, maintained at 37 C. Dishes were left undisturbed for ten days 
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to allow outgrowth of cells. After ten days, dishes were examined with an 
inverted light microscope to determine if outgrowth or microbial 
contamination had occurred. 
On the tenth day, the "spent" medium was removed and replaced with 
fresh medium. This was done in a laminar flow hood by carefully pouring 
off the old medium into a waste container. After pouring off medium, the 
edge of the dish was wiped with an alcohol soaked cloth to remove any 
medium that may have gotten on the outside of the dish. Five milliliters 
of fresh Ham's F-12 medium (same medium and technique as used in plating) 
was added to replace the "spent" medium. The medium was replaced every 
second day until outgrowth from the expiant covered half of the dish. This 
occurred in approximately three weeks following plating. 
Propagation of Cells 
Materials 
60 mm sterile petri dish 
Trypsin (Sigma Chemical Co., St. Louis, MO) 
Centrifuge tubes (sterile) 
Ham's F-12 medium 
Pasteur pipette (sterile) 
Parafilm "M" (American National Can, Greenwich, CT) 
Methods 
After growth had covered approximately half of the dish, cells were 
harvested and transferred to a new dish. In the laminar flow hood, medium 
was poured off and dish was rinsed with 1.5 ml trypsin (contains 2.5 g 
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trypsin/L dissolved in Hanks Balanced Salt Solution) to remove any 
remaining medium. Two milliliters of fresh trypsin were added to the dish. 
The dish was returned to the incubator for 13 minutes. After incubation 
with trypsin, the dish was returned to the laminar flow hood and a pasteur 
pipette was used to dislodge the coverslip. Cells were visible, trypsin 
caused the cells to detach from the dish and assume a spherical shape. 
Five milliliters of sterile Ham's F-12 medium was added to the cells, the 
mixture was gently pipetted to disperse cells. The medium containing cells 
was placed in a sterile centrifuge tube using a pasteur pipette. The tube 
was covered with parafilm, because the centrifuge was located outside of 
the laminar flow hood. The medium containing cells was centrifuged for one 
minute at 20 x g to collect cells. The upper portion of medium was gently 
pipetted off to prevent disturbance to the cells sedimented at the bottom 
of the tube. Approximately 1 mL of medium was left in the tube, which 
contained the cells. Approximately 4.5 mL fresh medium were added to the 
tube, a pasteur pipette was used to gently disperse cells and cells were 
transferred to a sterile 60 mm dish. Every second day, the medium was 
replaced with 5 mL fresh Ham's F-12 solution which contained 10% FBS and 
antimicrobials. After approximately five days, cells were ready for 
replating. An inverted light microscope was used to determine if cells 
were reaching confluency. Prior to confluency, cells were "trypsinized" as 
previously described except cells were placed in a sterile 100 mm dish. 
Every third day, the medium was replaced with 10 mL fresh Ham's F-12 
solution containing 10% FBS and antimicrobials. After approximately a 
week, cells were ready to be replated, prior to confluency. The medium was 
poured off, the dish was rinsed with 2 mL trypsin, 3 mL fresh trypsin was 
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added and returned to the incubator for thirteen minutes. After 
incubation, 5 mL Ham's F-12 containing 10% FBS and antimicrobials was added 
to the dish. A pasteur pipette was used to transfer cells to a sterile 
centrifuge tube, the tube was covered with parafilm and centrifuged for one 
minute at 20 x g. A pasteur pipette was used to remove approximately 7 mL 
medium without disturbing cells in the bottom of the tube. Approximately 
4.5 mL fresh Ham's F-12 containing 10% FBS and antimicrobials were added to 
the centrifuge tube and the mixture was gently pipetted to disperse cells 
evenly throughout the medium. Cells were divided evenly between two 
sterile 100 mm dishes. Ham's F-12 medium was added to the dishes to result 
in 10 mL volume. The medium was replaced with 10 mL fresh Ham's F-12 
solution every third day and cells were divided prior to 
confluency. Cells were replated at approximately 10 day intervals. 
Experimental Use of Fibroblasts 
Materials 
Materials were purchased from the following sources: MCDB 201 
medium, Ham's F-12 medium, penicillin, streptomycin sulfate, nystatin, 
trypsin and dexamethasone from Sigma Chemical Company (St. Louis, MO); 
leucine (14-C) and thymidine (3-H) from Amersham International (Amersham, 
UK); fetal bovine serum from Gibco Laboratories (Grand Island, NY); 
Universel ES from ICN Biochemicals, Inc. (Irvine, CA); petri dishes from 
Nunc (Roskilde, Denmark); testosterone, beta-estradiol and L-thyroxine from 
ICN Nutritional Biochemicals (Cleveland, OH); and insulin from Eli Lilly 
Inc. (Indianapolis, IN). GH was purified using the methods of Dellacha and 
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Sonnenberg (1964), Wall is and Dixon (1966) and Lorenson and Ellis (1975), 
as modified by J.L. Bobbitt (Eli Lilly Inc., Indianapolis, IN). 
Methods 
Cells were obtained and cultured as described above. Cells from 
third to tenth passage were used in the following experiments, with cell 
strains from different animals being utilized in different experiments. 
Cell count was approximated by use of a hemacytometer following treatment 
of dishes with trypsin. Cells were plated in triplicate 35 mm dishes 
containing 3 mL Ham's F-12 medium with 10% FBS and antimicrobials at 1.5 -
2.0 X 10^ cells/mL. Forty-eight hours later the medium was changed to MCDB 
201, prepared according to instructions with 1 x 10® U/L penicillin, 100 
mg/L streptomycin sulfate, 2.4x10® U/L nystatin and containing 0, 1 or 10% 
FBS. Cells were not disturbed for 48 to 72 hours to allow the cells to 
become quiescent. Medium was then replaced with 3 mL MCDB 201 containing 
14-C-leucine (approximately 90,000 dpm/dish, 57 mCi/mmol specific activity) 
and remained for the duration of the experiment. 3-H-thymidine 
(approximately 105,000 dpm/dish, 89 mCi/mmol specific activity) was added 
two hours prior to harvest of cells. 
Hormone additions and final concentrations used were: control - no 
hormones (C), dexamethasone (D) 25 ng/mL, estradiol (E^) .5 ng/mL, growth 
hormone (GH) 50 ng/mL, insulin (I) 2.5 ng/mL, testosterone (Tes) .5 ng/mL 
and thyroxine (T4) 100 ng/mL. D, E2 and Tes were dissolved in 95% ethanol, 
I was dissolved in pH 2.0 water and GH and T4 were dissolved in MCDB 201 
medium. 
Cells were harvested 48 hours after addition of hormones. The medium 
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was aspirated from the dish and each dish was rinsed with MCDB 201 medium. 
To dissolve the cells, 1 mL of 3 N NaOH was added and incubated for one 
hour at room temperature. Dissolved cells were placed in a glass 
scintillation vial. The dish was rinsed with 1 mL deionized water followed 
with .5 mL 6 N HCl to bring pH of the dissolved cells in the vial to near 
neutral. Universol ES (ICN Biochemicals Inc., Irvine, CA) was added to the 
vial for liquid scintillation counting. Thymidine and leucine 
incorporation were measured as dpm per dish. 
Statistical Analysis 
Data were analyzed by analysis of variance using the General Linear 
Models procedure of SAS (SAS, 1989). Results were expressed as least 
squares means, with differences between means separated on the basis of 
least significant differences using the predicted difference option (SAS, 
1989). 
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RESULTS 
Examination with an inverted light microscope revealed fibroblasts 
were growing from the tissue expiant. The fibroblasts surrounded the 
expiant and were spindle shaped, approximately double in length as compared 
with width of the cell. The cells adhered to the surface of the dish with 
the cells at the outer fringes of the outgrowth being more disperse and 
randomly oriented than ones near the expiant. With increasing cell number, 
orientation of the fibroblasts occurred with cells becoming parallel with 
each other. When a monolayer of fibroblasts covered the surface of the 
dish, confluency occurred and the cells ceased to grow. After cells were 
subjected to trypsin and replated, the cells became separated and randomly 
oriented. As cell numbers increased and they became more crowded, there 
was more orientation of cells in parallel rows. 
Serum 
The results from cells exposed to three levels of FBS for 48 hours 
are shown in Table 1. Cultured fibroblasts responded to FBS by increasing 
both thymidine and leucine incorporation. Results from cells harvested at 
one hour intervals from 24 to 48 hours after the addition of FBS to the 
medium are given in Figures 1 and 2. Thymidine and leucine incorporation 
were greatest by cells grown in the presence of 10% FBS (P < .05). Cells 
grown in medium lacking serum had the lowest thymidine and leucine 
incorporation. 
Hormones 
The results of addition of individual hormones to cultured 
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Table 1. Response of cultured bovine fibroblasts to 0, 1 or 10% FBS after 
48 hours 
FBS Thymidine Leucine 
% n dpm+SE n dpm+SE 
0 5 117±24® 7 176±20* 
1 6 280+22^ 6 1112±2lb 
10 6 818+22C 6 2525+21^ 
cleans without the same superscript within each column differ 
(P < .05). 
fibroblasts are given in Table 2. In serum-free medium, D or E2 decreased 
thymidine incorporation. I, T4 or GH treated cells were not different 
from C for thymidine incorporation in serum-free medium. The addition of 
1% FBS overcame the depression in thymidine uptake resulting from the 
addition of E2. In the presence of 1% FBS, I increased thymidine 
incorporation as compared with control cells. The addition of 1% FBS did 
not overcome the depression in thymidine incorporation due to the addition 
of D. 
In serum-free medium, D or I decreased leucine incorporation as 
compared with the control cells. GH, £3 or T^ treatment did not alter 
leucine uptake. Adding 1% FBS did not prevent depression of leucine 
incorporation causcd by D. Eg and GH depressed leucine incorporation, 
whereas, addition of I was not different from the control cells. One 
percent FBS with T4 increased leucine incorporation. 
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Figure 1. Thymidine incorporation 24 to 48 hours after FBS addition 
2000 
1500-
dpm 
1000 
300 
46 48 44 40 42 38 36 34 
Hours 
m 0% FBS + 1% FBS o 10% FBS 
Figure 2. Leucine incorporation 24 to 48 hours after FBS addition 
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Table 2. Bovine fibroblasts cultured for 48 hours in the presence of 
hormones and 0 or 1% FBS 
Thymidine Leucine 
0% FBS 1% 0% FBS 1% 
Treatment n dpm±SE n dpm+SE n dpm±SE n dpm+SE 
C 20 485±27^ 17 678±30^ 17 1602+44* 16 3447+45* 
Dex 7 356+46^ 7 439+46^ 5 1346±8lb 6 2914±74b 
E2 7 358+46^ 7 702±46^»c 6 1440±74a'b 6 3263+74C 
GH 7 456+463'^ 7 710+46*'^ 7 1584±69*'C 6 3266+74C 
I 6 388±50a'b 6 796±50C 8 1446±64b,c 6 3365±74*'^ 
Ta 6 459±50*'b 4 792±61*'C 6 1454+74*'^ 6 3679+74^ 
B'^Means without the same superscript within each column differ 
(P < .05). 
Table 3. Response of cultured fibroblasts to hormones after 48 hours 
in 17, FBS 
Thymidine Leucine 
Treatment n dpm+SE n dpm+SE 
C 3 140±14* 3 1182+50* 
I, Eg, GH 3 122+14* 3 919±50b 
I, T4, GH 3 119+14* 3 1063±50*'b 
I 2 178±17*'b 2 1155±61*'b 
Tes, Eg, GH, T^ 3 113±14* 3 1009±50b 
Ta, GH 3 199+14^ 3 1048+50*'b 
S'^Means without the same superscript within each column differ 
(P < .05). 
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The cells grown in the presence of 1% FBS and treated with hormone 
combinations are given in Table 3. The addition of T^ and GH increased 
thymidine uptake in cells cultured in 1% FBS. No combination of hormones 
or insulin alone increased leucine uptake. 
The results from addition of combinations of hormones to cultures of 
fibroblasts derived from a different animal and grown with or without FBS 
are shown in Table 4. In serum-free medium, the combination of I, GH and 
E2 stimulated thymidine uptake, but inhibited it in 1% FBS. T4 and GH did 
not alter thymidine incorporation from that of the control cells in serum-
free medium. In 1% FBS, thymidine incorporation was inhibited by T4 and 
GH. No combination of hormones increased leucine incorporation in 0 or 1% 
FBS. In 1% FBS, all combinations of hormones except I, T4 and GH inhibited 
leucine incorporation as compared with the control cells. 
Table 4. Cultured bovine fibroblasts response to combinations of hormones 
after 48 hours in 0 or 1% FBS 
Thymidine Leucine 
0% FBS 1% 0% FBS 1% 
Treatment n dpm+SE n dpm+SE n dpm+SE n dpm±SE 
C 2 97+23* 3 270+19* 3 315+24* 3 451±24* 
I, GH, E2 2 248±23b 2 167+23^ 2 292+30*'b 3 310±24b 
I, T4, GH 3 146±19*'b 3 250+19* 3 355+24* 3 433+24*'b 
I, T4, GH, E2 3 119±19* 3 230±19*'b 3 292+24*'b 3 368±24b 
T4, GH, Tes 3 95+19* 3 189+19^ 3 241+24^ 2 358±30b 
Ta, GH 3 103+19* 3 144+19^ 3 251+24*'b 3 311+24^ 
S'^Means without the same superscript within each column differ 
(P < .05). 
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DISCUSSION 
To our knowledge, this is the first use of ear biopsies to obtain 
cells from cattle for culturing. The sample could be easily obtained 
within a few minutes while the animal was restrained in a head-gate without 
the administration of anesthetic. Animals could also be sampled again at 
later times. 
Early attempts involving removal of hair (shaving with a razor or 
chemical hair remover) and sterilization (iodine surgical scrub and 
alcohol) prior to tissue biopsy were no more effective in preventing 
microbial contamination than increasing antibiotic concentration in the 
transport medium and use of a microtome to remove the epidermis. Rinsing 
the skin sample in a weak chlorine solution or passing sample through a 
flame prior to slicing did not reduce contamination compared with the 
method described. It is very important to maintain conditions as sterile 
as possible to prevent microbial contamination of the cultures. Viable 
tissue was obtained, which allowed outgrowth of fibroblasts. Resulting 
fibroblasts could be used in studies several months after obtaining sample 
from the animal, if the cells continued to grow and were replated. 
MCDB 201 medium was developed to allow the growth of fibroblasts 
without the addition of serum. However, adding serum to this medium 
increased both thymidine and leucine uptake of bovine fibroblasts. Ten 
percent FBS dramatically increased leucine incorporation by bovine 
fibroblasts. FBS contains nutrients, hormones and growth factors to meet 
the growth requirements of fibroblasts. 
In serum-free medium, no hormone by itself was mitogenic to bovine 
fibroblasts. The lack of response from GH addition in serum-free medium 
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was similar to findings with human fibroblasts (Cook et al., 1988). In 
cattle, GH increased rate of gain (Moseley et al., 1990) with IGF-I being 
credited for this growth promotion (Brier et al., 1988) because GH 
stimulates IGF-I production (Salmon and Daughaday, 1957). IGF-I has been 
shown to stimulate thymidine and leucine incorporation in human fibroblasts 
(Conover et al., 1983; Conover et al., 1985b). 
It has been reported that glucocorticoids decreased the rate of 
progression of chick embryo fibroblasts through the Gj phase of the cell 
cycle resulting in fewer cells synthesizing DNA at a given time (Fodge and 
Rubin, 1975). This same phenomenon may have occurred in the bovine 
fibroblasts, and would explain the resulting decrease in thymidine 
incorporation following D addition to the cells. The factors contained in 
1% FBS were not sufficient to overcome the depressing effect of D on bovine 
fibroblasts. However, adding 10% FBS overcame the depression due to the 
addition of D (data not shown). 
Exogenous estrogens improved weight gain of cattle (Burroughs et al., 
1954; Brier et al., 1988). Animals treated with E2 have increased liver 
(Preston, 1975) and anterior pituitary weights and circulating levels of GH 
and I (Trenkle and Burroughs, 1967). The bovine fibroblasts did not 
respond to Eg, which lends support to the theory that Eg action may be 
mediated through GH and IGF-I (Plouzek and Trenkle, 1991b). 
I alone did not increase thymidine incorporation in cells cultured in 
serum-free medium. The combination of I and 1% FBS resulted in increased 
thymidine incorporation as compared with C. Serum contains platelet 
derived growth factor that acts as a competence factor to allow cells to 
enter the cell cycle (O'Keefe and Pledger, 1983). Insulin present in high 
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concentrations can stimulate the type I IGF-I receptor (Massague and Czech, 
1982) which would allow insulin to act as a progression factor and 
stimulate the cells to proceed through the cell cycle and increase 
synthesis of DNA. The I level used in this experiment was five to ten 
times greater than what is found in plasma of cattle and may have been 
acting as a progression factor (Plouzek and Trenkle, 1991b). 
Treatment with T^ increased weight gain and skeletal growth in 
neonatal hypophysectomized rats (Glasscock et al., 1991). The thyroid 
gland also regulates GH synthesis and therefore, IGF-I production. In 
cultured human epithelial cells, T^ added to Eagle's minimum essential 
medium containing 10% FBS increased thymidine incorporation (Siegel and 
Tobias, 1966). Since T4 did not stimulate thymidine incorporation without 
serum in bovine fibroblasts, it appears that T4 acts indirectly in 
regulating fibroblast growth. The increased leucine incorporation 
following T4 addition may have resulted from cellular production of a 
growth factor, such as epidermal growth factor (EGF) by bovine fibroblasts. 
Thyroid hormones have been implicated in regulating EGF production in 
neonatal skin (Hoath et al., 1983). EGF has been reported to increase 
protein synthesis in expiants of chick embryo epidermis (Hoober and Cohen, 
1967). 
Combinations of hormones did not stimulate the uptake of thymidine 
consistently. In one experiment, T4 and GH increased thymidine 
incorporation in the presence of 1% FBS (Table 3), in a second experiment 
it did not (Table 4). Cells used in these two experiments were from 
different animals of similar ages which might have been a factor. 
The combination of I, GH and E2 stimulated thymidine incorporation in 
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0% FBS. This anomaly is unexplained. In 0% FBS, none of these three 
hormones alone or with T4 resulted in increased thymidine incorporation. 
In 1% FBS, thymidine incorporation was not stimulated by this combination 
of three hormones. In a human breast cancer cell line, the combination of 
I and E2 increased DNA content per dish in medium supplemented with 
steroid-stripped serum with I being more mitogenic than Eg (Van der Burg 
et al., 1988). 
The addition of Tes with GH, Eg and T4 did not stimulate thymidine or 
leucine incorporation. It appears that these hormones may act via growth 
factors rather than by direct stimulation of cells to increase growth of 
animals. 
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CONCLUSIONS 
Fibroblasts were cultured from the dermal tissue from the ear of 
cattle. These fibroblasts responded dramatically to the addition of one or 
ten percent FBS to the medium by increasing uptake of thymidine and 
leucine. 
The hormones known to stimulate animal growth did not appear to be 
primary determinants of growth of these cells. The hormones had little or 
no effect on DNA and protein synthesis in medium without serum; however, 
factors contained in the serum modulated the response of bovine fibroblasts 
to hormones. In the animal, it appears that these hormones might function 
through increased production of growth factors rather than by a direct 
stimulation of cell growth. 
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SECTION II. 
THE EFFECTS OF EGF AND IGF-I ON GROWTH 
OF BOVINE FIBROBLASTS 
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INTRODUCTION 
Various growth factors that stimulate cellular proliferation have 
been identified. Epidermal growth factor (EGF) and insulin-like growth 
factor-I (IGF-I) are two growth factors that have been shown to alter 
growth rate in cells of human and laboratory animals (Westermark and 
Heldin, 1985; Shipley et al., 1989; Conover et al., 1987b). Synthesis of 
nucleic acids is stimulated by EGF (Waterfield, 1989) and IGF-I (Furlanetto 
and DiCarlo, 1984) in human and rodent cells. 
Bovine fibroblasts have not been extensively studied in cell culture 
and consequently their requirement for growth factors has not been 
characterized. Cattle respond to exogenous estrogen with increased weight 
gains (Brier et al., 1988), whereas, rodents exhibit decreased weight gains 
(Heywood and Wadsworth, 1980). Because cattle respond differently to 
exogenous hormones, it has been speculated that bovine cells may respond to 
growth factors in a different manner than human or rodent cells. 
The purpose of these studies was three-fold. The objectives of Study 
I were to determine if IGF-I or EGF altered the growth of bovine 
fibroblasts and to determine the appropriate concentrations of the growth 
factors. The objectives of Study II were to determine if frequency of 
administration affected cell growth and if the combination of EGF and IGF-I 
increased cell growth more than either growth factor alone. The objectives 
of Study III were to determine if growth factors and hormones affected 
growth more than growth factors or hormones alone. 
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MATERIALS AND METHODS 
Materials 
Materials were purchased from the following sources: epidermal 
growth factor, MCDB 201 powdered medium, Ham's F-12 powdered medium, 
penicillin, streptomycin sulfate, nystatin, trypsin and dexamethasone from 
Sigma Chemical Company (St. Louis, MO); insulin-like growth factor-I from 
Imcera Bioproducts, Inc. (Terre Haute, IN); leucine (14-C) and thymidine 
(3-H) from Amersham International (Amersham, UK); fetal bovine serum (FBS) 
from Gibco Laboratories (Grand Island, NY); Universol ES from ICN 
Biochemicals, Inc. (Irvine, CA); petri dishes from Nunc (Roskilde, 
Denmark); Stadie-Riggs microtome from Thomas Scientific (Swedesboro, NJ); 
beta-estradiol and L-thyroxine from ICN Nutritional Biochemicals 
(Cleveland, OH); and insulin from Eli Lilly Inc. (Indianapolis, IN), GH 
was purified using the methods of Dellacha and Sonnenberg (1964), Wallis 
and Dixon (1966) and Lorenson and Ellis (1975) as modified by J.L. Bobbitt 
(Eli Lilly Inc., Indianapolis, IN). 
Methods 
Cells were cultured and propagated as described in Section I. EGF 
was added at 0, 2.5, 5.0, 7.5 or 10 ng/mL and IGF-I at 0, 25, 50, 75 or 100 
ng/mL for Study I. In Study II, 5 ng/mL EGF and 50 ng/mL IGF-I alone and 
in combination were used. Additions of growth factors were made at twelve 
hour intervals at 0; 0 and 12; or 0, 12 and 24 hours. The combination of 
EGF and IGF-I was administered in the following manner: EGF was given at 0 
hour and IGF-I was given at 0, 12 or 24 hours. In all comparisons, the 
final total quantities added were 5 ng/mL EGF and 50 ng/mL IGF-I. In Study 
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III, hormone additions and levels used: Control (C) - no hormones, 
dexamethasone (D) 25 ng/mL, estradiol (E^) .5 ng/mL, growth hormone (GH) 50 
ng/mL and thyroxine (T^) 100 ng/mL. D and £3 were dissolved in 95% 
ethanol. GH and T4 were dissolved in MCDB 201 medium. Hormones were added 
at 0 hour. EGF and IGF-I were added at three times (0, 12 and 24 hours) to 
give a final concentration of 5 ng/mL EGF and 50 ng/mL IGF-I. 
Cells were exposed to 14-C-leucine (approximately 80,000 dpm/dish, 57 
mCi/mmol specific activity) for the duration of the experiments. The 
addition of 3-H-thymidine (100,000 dpm/dish, 89 mCi/mmol specific activity) 
was made two hours prior to harvest of cells. 
Cells were harvested 48 or 96 hours after adding growth factors in 
Studies I and III. Cells were harvested 48 hours after the initial 
addition of growth factors in Study II. 
To harvest cells, the medium was aspirated from the dish. Each dish 
was rinsed with fresh non-radioactive MCDB 201 medium. To dissolve the 
cells, 1 mL of 3 N NaOH was added and incubated for one hour at room 
temperature. Dissolved cells from the dish were transferred to a glass 
scintillation vial. The dish was rinsed with 1 mL deionized water and .5 
mL 6 N HCl to bring pH of the dissolved cells in the vial to near neutral. 
Universol ES was added to the vial for scintillation counting. Thymidine 
and leucine incorporation were measured as disintegrations per minute (dpm) 
per dish. 
Statistical Analysis 
All experimental treatments were tested in triplicate within a study. 
Study I and II were repeated. The results are expressed as least squares 
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means, using General Linear Models procedure of SAS (SAS, 1989). 
Differences between least squares means were separated on the basis of 
least significant differences using the predicted difference option (SAS, 
1989). 
48 
RESULTS 
Study I 
Addition of EGF to fibroblasts in MCDB 201 medium with 1% FBS 
resulted in significant stimulation of DNA synthesis (Table 1). At 48 
hours, all additions of EGF increased thymidine incorporation, but only 5 
ng/mL was significant. At 96 hours, maximum incorporation was obtained 
with 5 ng/mL EGF. 
Table 1. The alteration in thymidine uptake by cultured bovine fibroblasts 
due to the addition of different levels of EGF in medium 
containing 1% FBS following 48 or 96 hours of exposure 
Treatment 48 hours 96 hours 
ng/mL n dpm+SE n dpm+SE 
0 6 408+276* 8 349+226* 
2.5 6 1063+2763'^ 6 1482±276b 
5.0 6 1285+276^ 6 2526+276C 
7.5 6 1162+2763'^ 6 1322±276b 
10.0 6 1085+276*'^ 6 1232±276^ 
a , b ,Cf^eans without the same superscript within each column differ 
(P < .05). 
Addition of IGF-I in MCDB 201 with 1% FBS resulted in a 
nonsignificant increase in thymidine incorporation with increasing 
quantities of IGF-I at 48 hours and no definite trend at 96 hours (Table 
2). Cells harvested at 96 hours had a lower level of thymidine 
incorporation per unit of time than cells harvested at 48 hours, indicating 
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a decrease in DNA synthesis as the culture aged. The reduced growth at 96 
hours indicated that the growth requirement needs of the cells were not 
being met and that unidentified factors in the medium or serum may have 
been utilized by cells treated with IGF-I. 
The effect of EGF on leucine incorporation is shown in Table 3. At 
48 hours, cells exposed to 5 ng/mL EGF had the greatest leucine 
incorporation, while other levels of EGF were not different from the 
control cells. All levels of EGF increased leucine incorporation at 96 
hours (P < .05). 
The response of the cells to IGF-I is shown in Table 4. All 
additions of IGF-I except 25 ng/mL at 48 hours increased protein synthesis. 
Control cells did not have markedly greater leucine incorporation at 96 
hours as compared with 48 hours. The amount of leucine incorporated per 
hour was less at 96 hours than for cells harvested at 48 hours. There 
appears to be a decrease in protein synthesis rate as the cultures aged. 
Table 2. The alteration in thymidine uptake by cultured bovine fibroblasts 
due to the addition of different levels of IGF-I in medium 
containing 1% FBS following 48 or 96 hours of exposure 
Treatment 48 hours 96 hours 
ng/mL n dpm+SE n dpm+SE 
0 6 408+276 8 349±226 
25 6 550+276 6 424±276 
50 6 711±276 6 389±276 
75 6 768±276 6 542±276 
100 6 842±276 6 464±276 
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Table 3. The alteration in leucine uptake by cultured bovine fibroblasts 
due to the addition of different levels of EGF in medium 
containing 1% FBS following 48 or 96 hours of exposure 
Treatment 48 hours 96 hours 
ng/mL n dpm+SE n dpm+SE 
0 6 1470+201* 8 1898±165* 
2.5 6 1786+201* 6 3352+20lb,c 
5.0 6 2160+20lb 6 3032+20lb,c 
7.5 6 1871±201* 6 2903+20lb 
10.0 6 1695+201* 6 3468+201C 
cleans without the same superscript within each column differ 
(P < .05). 
Table 4. The alteration in leucine uptake by cultured bovine fibroblasts 
due to the addition of different levels of IGF-I in medium 
containing 1% FBS following 48 or 96 hours of exposure 
Treatment 48 hours 96 hours 
ng/mL n dpm+SE n dpm+SE 
0 6 1470±201* 8 1898+165* 
25 6 2017±201*'b 6 3027±20lb,c 
50 6 2334±20lb 6 2580±20lb 
75 6 2469±20lb 6 3056±20lb,c 
100 6 2458+201% 6 3589±20lC 
*'b,CMgans without the same superscript within each column differ 
(P < .05). 
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Study II 
It was determined in Study I that 5 ng/mL EGF resulted in optimum 
incorporation of leucine and thymidine uptake and was selected for use in 
the second study. For IGF-I, 50 ng/mL was selected based on a review of 
the literature and the response to IGF-I in Study I. It has been reported 
that making small additions of IGF-I at hourly intervals increased DNA 
synthesis in baby hamster kidney fibroblasts compared with a single 
addition at the beginning (Blum et al., 1989). Therefore, increasing the 
number of administration times for EGF and IGF-I was investigated. 
The results of the cells grown in the presence of 1% FBS are given in 
Table 5. EGF or IGF-I administration increased thymidine uptake. The 
increase in thymidine incorporation was greater for the combination of EGF 
and IGF-I than EGF given at one or two times or IGF-I given at one, two or 
three times. EGF increased leucine uptake (P < .01), with greatest 
response seen when given at three times. IGF-I given at one time increased 
leucine incorporation more than EGF given at one time. IGF-I given at two 
or three times increased leucine incorporation more than EGF given at two 
or three times. The combination of EGF with IGF-I was not better than IGF-
I given at two times. 
The results from cells grown in serum-free medium are given in Table 
6. EGF given at one time and EGF with IGF-I increased thymidine 
incorporation; whereas, IGF-I alone did not. Multiple doses of EGF or IGF-
I were not effective. The combination of EGF and IGF-I increased thymidine 
incorporation. Adding EGF alone at one, two, or three times did not 
increase leucine incorporation. IGF-I increased leucine uptake as compared 
with control cells. IGF-I given at one time stimulated more leucine uptake 
52 
Table 5. Alteration in frequency of administration and combination of EGF 
and IGF-I on thymidine or leucine incorporation of cultured 
bovine fibroblasts in the presence of 1% FBS at 48 hours 
Thymidine Leucine 
Treatment n dpm±SE n dpm+SE 
Control 6 229±26* 6 1491+57* 
EGF/IGF-I 6 548+26C 6 2348±57® 
EGF - 1 time 6 362+26% 6 1548+57*'^ 
EGF - 2 times 6 342+26% 6 1755±57b,c 
EGF - 3 times 6 459±26b'C 6 1826±57C 
IGF-I - 1 time 6 361±26b 6 1949±57C,d 
IGF-I - 2 times 6 353+26^ 6 2140+57d,e 
IGF-I - 3 times 6 336+26^ 6 2091+57^ 
a,b,c,d,e^g3P5 without the same superscript within a column differ 
(P < .01). 
Table 6. Alteration in frequency of administration and combination of EGF 
and IGF-I on thymidine or leucine incorporation of cultured 
bovine fibroblasts in the presence of 0% FBS at 48 hours 
Thymidine Leucine 
Treatment n dpm+SE n dpm+SE 
Control 11 285+24* 10 523+44* 
EGF/IGF-I 12 384±2lb 11 918+40b 
EGF - 1 time 9 362±26b 9 534±47* 
EGF - 2 times 12 331+21*'b 12 545±38* 
EGF - 3 times 12 329±21*'b 12 538+38* 
IGF-I - 1 time 9 306±26* 9 I242+47C 
IGF-I - 2 times 12 318+21* 12 713±38d 
IGF-I - 3 times 12 279+21* 12 686+38^ 
a,b,c,dMeans without the same superscript within a column differ 
(P < .05). 
53 
than did EGF given at one time. A similar response was seen with IGF-I 
given at two or three times. 
Study III 
The results from combinations of hormones with growth factors are 
given in Tables 7 through 9. The combination of D with IGF-I did not 
affect thymidine incorporation (Table 7); whereas, the growth factors alone 
or in combination increased thymidine uptake at 48 hours. At 96 hours, D 
and IGF-I inhibited thymidine incorporation. The growth factors did not 
stimulate thymidine uptake at 96 hours. At 48 hours, leucine incorporation 
was increased by all treatments as compared with the controls. At 96 
hours, D and IGF-I combination was not different from control cells but the 
Table 7. The effect of hormones and growth factors on thymidine 
incorporation in bovine fibroblasts in 1% FBS at 48 
or 96 hours 
Thymidine Leucine 
48 hours 96 hours 48 hours 96 hours 
Treatment n dpm+SE n dpm+SE n dpm+SE n dpm±SE 
Control 3 344+40* 3 344±40* 3 2310+114* 3 2297+114* 
D, IGF-I 3 366±40*'b 3 210±40b 3 2688+114^ 3 2319±114* 
EGF 3 618±40C 3 289±40*'b 3 2815±114b'C 3 2897+114^ 
EGF, IGF-I 2 571±48C 3 427±40® 3 3453+114^ 3 3786+114C 
IGF-I 3 487±40b,c 3 310±40a*b 3 3I08±114C 3 2978±114^ 
cleans without the same superscript within a column differ 
(P < .05). 
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Table 8. The effect of hormones and growth factors on cultured bovine 
fibroblasts in 1% FBS at 48 hours 
Thymidine Leucine 
Treatment n dpm+SE n dpm±SE 
Control 3 365±29* 3 1389+64* 
EGF 3 159±29b,c 3 1054±64b 
E2 3 163±29b,c 3 949+64^ 
Eg, EGF 3 157+29b,c 3 985±64b 
Eg, IGF-I 3 235±29b,c 3 1544±64C 
GH 3 204±29b'C 3 949±64a,b 
GH, EGF 3 165±29b,c 3 993±64^ 
GH, IGF-I 3 186±29b'C 3 1682±64C 
IGF-I 3 408+29® 3 2051+64^ 
T4 3 167±29b'C 3 906+64% 
T4, EGF 3 174±29b'C 3 1058+64% 
T4, IGF-I 3 189±29b,c 3 I79O+64C 
T4, GH, EGF 3 150+29^ 3 920+64% 
T4, GH, IGF-I 3 I85+29C 3 1670±64C 
10% FBS 3 930+29^ 3 2689±64® 
a,b,c,d,eMeans 
(P < .05). 
without the same superscript within a column differ 
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addition of growth factors alone or in combination increased leucine 
incorporation as compared with the control cells. 
Ten percent serum increased thymidine incorporation, whereas, growth 
factors and/or hormones additions resulted in decreased thymidine uptake 
(Table 8). Leucine incorporation was increased by IGF-I alone or in 
combination with hormones. However, no combination of hormone and IGF-I 
increased leucine incorporation more than IGF-I alone. E6F addition, alone 
or in combination with hormones, decreased leucine incorporation. Hormones 
alone were unable to stimulate leucine or thymidine incorporation. 
A similar experiment was performed using cells from a different 
animal of similar age and genetic background (Table 9). At 48 hours, EGF 
in combination with T^ increased thymidine uptake. The combination of GH, 
T4 and EGF increased thymidine uptake. However, this was not greater than 
T4 and EGF. At 96 hours, EGF alone or T4 with IGF-I increased thymidine 
uptake. At 48 hours, leucine incorporation was increased by IGF-I; IGF-I 
with Eg; IGF-I, T4 and GH; or EGF, T4 and GH. At 96 hours, cells treated 
with IGF-I except those treated with IGF-I, T4 and GH had greater leucine 
incorporation than the control cells. EGF was not effective in stimulating 
leucine uptake except in combination with T4. 
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Table 9. The effect of hormones and growth factors on thymidine and 
leucine incorporation in bovine fibroblasts in 1% serum at 48 
or 96 hours 
Thymidine Leucine 
48 hours 96 hours 48 hours 96 hours 
Treatment n dpm±SE n dpm±SE n dpm±SE n dpm+SE 
Control 3 237±40* 3 287+40* 3 1130±83* 3 1265±83* 
EGF 3 315+40^'^ 3 327±40b 3 1218+83*,b 3 1410±83*'b 
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IGF-•I 3 255+40* 3 249+40* 3 1477±83b 3 1599±83b,c,d 
GH, EGF 2 318±48®'b 3 311±40*,b 3 1226+83*'b 3 1426+83*,b 
GH, IGF-•I 3 270+40® 3 294+40*,b 3 1310±83*'b 3 1519+83b,d 
IGF-•I 3 339±40a,b 3 342+40*,b 3 1417±83b 3 1765±83C 
T4. EGF 3 403+40b,c 3 305+40*,b 3 1360+83*,b 3 1528+83b,c,d 
T4, IGF-•I 3 301±40®'b 3 407±40b 3 1360+83*,b 3 1707+83C,d 
T4, GH, EGF 3 477±40C 3 281±40* 3 1481±83b 3 1370±83*'b 
T4, GH, IGF-I 3 232+40* 3 313±40*,b 3 1400±83b 3 1477±83*'b,d 
a,b,c,df^g3P5 without the same superscript within a column differ 
(P < .05). 
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DISCUSSION 
Most of the research examining the effects of growth factors on 
fibroblasts has used cells of human or rodent origin. There are two types 
of factors (competence and progression) in serum to stimulate mitosis in 
cells (Pledger et al., 1978). EGF and IGF-I are progression factors which 
allow cells to exit Gj and enter into S phase of the cell cycle (O'Keefe 
and Pledger, 1983). The bovine cells were grown in the presence of 0 or 1% 
FBS. In Section I, bovine cells responded to the presence of 1% PBS by 
increasing thymidine and leucine incorporation as compared with cells grown 
in serum-free medium. The bovine cell response to growth factors was 
modulated by the presence of FBS. Serum contains both competence and 
progression factors in an undefined mix, along with hormones and nutrients 
to regulate cellular growth. The addition of EGF or IGF-I with FBS may 
allow cells to proceed through the cell cycle, because these combinations 
may contain adequate amounts of competence and progression factors to 
stimulate cells to traverse the cell cycle. 
EGF at 5 ng/mL increased DNA synthesis in these fibroblasts in all 
experiments except one. In these studies, the minimal time required for 
EGF presence to stimulate DNA synthesis in bovine fibroblasts was not 
examined. Some researchers have determined that DNA synthesis increased in 
human fibroblasts after exposure to EGF for eight hours (Westermark and 
Heldin, 1985). Others have reported that up to twelve hours exposure to 
EGF is required to increase DNA synthesis (Carpenter and Cohen, 1976). 
Maximal stimulation of DNA synthesis occurred approximately 20 hours after 
EGF addition in mouse keratinocytes (Zendegui et al., 1988). Chick embryo 
epidermis expiants, grown in the absence of serum, had the greatest 
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thymidine uptake following 24 to 48 hours of EGF exposure (Bertsch and 
Marks, 1974). 
EGF stimulated leucine incorporation in bovine fibroblasts in all 
experiments but one. Leucine incorporation was not dramatically different 
at 48 or 96 hours in these bovine fibroblasts. It is unknown why the cells 
in this one experiment (Table 8) decreased thymidine and leucine 
incorporation due to the addition of EGF. It has been reported that chick 
embryo fibroblasts increased protein synthesis two-fold during the first 
forty-eight hours of incubation with EGF as compared with control cells 
(Hoober and Cohen, 1967). 
Bovine fibroblasts grown in 1% FBS did not respond to IGF-I by 
increasing the rate of thymidine incorporation in all experiments. In one 
experiment, IGF-I decreased thymidine uptake as compared with control 
cells; however, usually there was a nonsignificant or significant increase 
in thymidine uptake following IGF-I addition when cells were harvested at 
48 or 96 hours. In human fibroblasts, peak thymidine incorporation was 
seen 22 to 28 hours after IGF-I addition (Conover et al., 1987b). Human 
fibroblasts exhibited increased thymidine uptake for approximately 40 hours 
following IGF-I addition. The peak incorporation time for IGF-I 
stimulation in bovine fibroblasts was not determined. 
In the second study, the addition of all levels of IGF-I increased 
rate of DNA synthesis when cells were harvested 48 hours after initial 
addition of 50 ng/mL IGF-I. This is in the range of IGF-I (10-100 ng/mL) 
levels that have been reported to stimulate DNA and protein synthesis of 
human fibroblasts (Conover et al., 1985b). 
Combining EGF with IGF-I enhanced thymidine and leucine uptake in 
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bovine fibroblasts compared to the control cells. Other research has shown 
that EGF and IGF-I work at different places within the cell cycle (O'Keefe 
and Pledger, 1983). EGF is required for cells to leave GG, with EGF being 
required during the first 6 hours and IGF-I during the last 6 hours of GG 
to stimulate DNA synthesis. This would agree with the research showing EGF 
needs to be present for 8 hours to stimulate DNA synthesis (Westermark and 
Heldin, 1985). The bovine fibroblasts did not have a dramatic response to 
the combination of EGF/IGF-I. However, these bovine fibroblasts were grown 
in 1% FBS. There may have been adequate levels of EGF or IGF-I contained 
in the FBS to enable the cells to exit the Gq/Gj phase of the cell cycle. 
In serum-free medium, the combination of EGF and IGF-I stimulated thymidine 
incorporation but this was not better than EGF given at one time. 
In these studies, there was not seen a clearly mitogenic response to 
multiple administrations of IGF-I. Twelve hour intervals may have been too 
wide or fibroblasts do not respond in the same manner as hamster 
fibroblasts, which increased DNA synthesis in response to hourly additions 
of IGF-I (Blum et al., 1989). 
In serum-free medium, only the combination of EGF with IGF-I or EGF 
given at one time increased thymidine uptake. There may not have been 
adequate EGF present at one time from the multiple doses to stimulate the 
cell receptors to allow increased DNA synthesis. The cells may have 
stopped in the first half of the Gg, where EGF is necessary to allow 
cellular progression through Gg/Gj to S phase. IGF-I has been shown to be 
necessary in the second half of Gg. If the cells were in the first portion 
of Gg, the cells may not proceed through the rest of the cell cycle without 
EGF. This may explain why there were varied responses to the presence of 
60 
EGF or IGF-I in the different experiments. In some experiments there was 
increased thymidine uptake at 48 hours due to the addition of EGF to medium 
containing 1% FBS (Table 5); whereas, in others there was no increase 
(Table 9). Some cells did not increase thymidine incorporation due to the 
addition of IGF-I (Table 2); whereas, other cells grown in 1% FBS increased 
thymidine uptake (Table 5). Cells from different donor animals were used 
in these experiments. The cells from different donors did not respond to 
growth factors and/or hormones in the same manner. The cause of this 
variation is unknown at the present time. Similarly, response of human 
fibroblast cultures to EGF treatment ranged from increased to decreased 
thymidine uptake when cells from various human donors were tested (Lechner 
et al., 1989). 
In 1% FBS, EGF, IGF-I or combination of these two growth factors 
increased protein synthesis by bovine fibroblasts. In 0% FBS, EGF alone 
was not effective in increasing leucine uptake. IGF-I was more stimulatory 
to leucine incorporation than EGF. IGF-I given at one time increased 
leucine uptake more than IGF-I given at multiple times in serum-free 
medium. It appears a threshold amount of IGF-I may be needed to stimulate 
protein synthesis. 
In Section I, D inhibited thymidine and leucine uptake. The addition 
of IGF-I with D prevented this inhibition. However at 96 hours, IGF-I did 
not prevent the inhibition due to D. IGF-I may have a shorter half-life in 
the medium than did D. 
Hormones combined with the growth factors did not increase leucine 
incorporation more than growth factors alone. The hormones did not appear 
to have direct control of protein synthesis in bovine fibroblasts. In 
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animals, hormones are probably stimulating growth factor production, be it 
endocrine, paracrine or autocrine to increase protein synthesis. 
EGF and T4 increased thymidine uptake in one experiment (Table 9); 
however, this was not seen in another experiment (Table 8). This increase 
in thymidine uptake was-not greater than by cells given EGF alone (Table 
9). The combination of EGF, T4 and GH stimulated more thymidine 
incorporation than did EGF alone (Table 9); however, this combination 
inhibited thymidine incorporation in other cells (Table 8). It has been 
reported that T4 was involved in regulating EGF production in neonatal skin 
(Hoath et al., 1983). If this were true in bovine fibroblasts, it seems 
there should have been a more consistent response to T4. FBS was more 
effective than any combination of hormone and growth factors for 
stimulating thymidine and leucine uptake. 
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CONCLUSIONS 
Bovine fibroblasts may respond to the addition of growth factors by 
increasing thymidine and leucine incorporation. However, cells from one 
animal decreased thymidine and leucine incorporation due to the addition of 
EGF or IGF-I to the medium. IGF-I addition to cultured bovine fibroblasts 
increased leucine uptake in all experiments, but IGF-I stimulated thymidine 
uptake in half of the experiments. EGF-I stimulated thymidine 
incorporation in some experiments; however, some cells did not respond to 
EGF. Cells from one animal decreased thymidine incorporation due to the 
addition of EGF to the medium. EGF stimulated, decreased or had no effect 
on leucine incorporation in bovine fibroblasts derived from different donor 
animals. More frequent administration of smaller amounts of EGF or IGF-I 
was not dramatically better than adding growth factors at one time. Ten 
percent serum was more effective in stimulating thymidine and leucine 
incorporation than IGF-I, EGF or a combination of a growth factor with 
hormones. Combinations of hormones with a growth factor did not result in 
a dramatic increase in thymidine or leucine incorporation in bovine 
fibroblasts. 
Either EGF or IGF-I stimulated leucine incorporation in bovine 
fibroblasts, however, IGF-I appeared to be more stimulatory to protein 
synthesis than EGF. 
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SECTION III. 
COMPARISON OF GROWTH OF BOVINE FIBROBLASTS 
IN CULTURE WITH GROWTH OF DONOR ANIMALS 
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INTRODUCTION 
Lean meat must be produced efficiently and economically, 
necessitating the identification of breeding stock possessing desirable 
genetic characteristics for producing this lean beef. The desire to 
accurately predict animal growth has intrigued animal scientists for years. 
Some research has compared mature carcass weight with individual 
muscle weights (Orme et al., 1960; Butterfield, 1962). More sophisticated 
analytical assays allowed the examination of DNA and RNA content of 
dissected muscle to determine if differences existed among animals with 
different growth potentials (Trenkle et al., 1978). 
Examination of blood concentrations for hormones (Trenkle and Topel, 
1978; Verde and Trenkle, 1987; and Plouzek and Trenkle, 1991a) and growth 
factors (Plouzek and Trenkle, 1991b) allowed animals to be spared while 
measurements could be made. The next logical development was obtaining 
tissue biopsies for determining mRNA levels (Hannon et al., 1991) or 
culturing cells to study growth of cattle. 
Animal growth, as measured by weight gain, represents an increase in 
cell number, an increase in cell size or a combination of these. It is 
possible to determine cellular incorporation of radiolabeled thymidine and 
leucine into DNA and protein as measures of cell growth by use of cell 
cultures. Mammalian skin fibroblasts can be easily cultured and maintained 
in a laboratory environment. 
During the establishment of fibroblast cultures from different 
calves, an observation was made that outgrowth of cells from expiants 
appeared to be related to growth rates of donor animals. The growth of 
fibroblast cultures from different breeds and ages of purebred and 
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crossbred cattle was studied to determine if there was a relationship 
between growth of cells in culture and growth of donor animals. 
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MATERIALS AND METHODS 
Materials 
Materials were purchased from the following sources: Ham's F-12 
powdered medium, penicillin, streptomycin sulfate, nystatin and giemsa from 
Sigma Chemical Company (St. Louis, MO); leucine (14-C) and thymidine (3-H) 
from Amersham International (Amersham, UK); fetal bovine serum (FBS) from 
Gibco Laboratories (Grand Island, NY); Universel ES from ICN Biochemicals. 
Inc. (Irvine, CA); petri dishes from Nunc (Roskilde, Denmark); Stadie-Riggs 
Microtome from Thomas Scientific (Swedesboro, NJ); glass covers!ips and 
methanol from Fisher Scientific (Chicago, IL); and high vacuum grease from 
Dow Corning (Midland, MI). 
Methods 
Five groups of animals were sampled from beef herds maintained at the 
Iowa State University Beef Nutrition (Charolais-Simmental crossbred cattle) 
and Teaching farms (purebred Simmental and Angus cattle). Eighty-seven 
animals were sampled over a two year period: Group I: Angus fall calves, 
sampled at approximately 3 mo; Group II: Charolais-Simmental crossbred 
calves, sampled within 1 mo of birth and again at approximately 5 mo; Group 
III: Angus and Simmental bulls sampled at 8 mo; Group IV: Charolais-
Simmental crossbred calves sampled at 7 mo; and Group V: Angus cows, 
ranging in age from 3 to 11 years. 
Samples of skin were collected via punch biopsy and plated as 
described in Section I, except one piece of tissue per animal was 
aseptically plated in three 35 mm petri dish in 3 mL sterile Ham's F-12 
medium. Radiolabeled 14-C-leucine (approximately 50,000 dpm/dish, 57 
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mCi/mmol specific activity) was added at time of plating to the culture 
medium to estimate protein synthesis. One piece of tissue was plated in 5 
mL of nonradioactive Ham's F-12 medium in triplicate 60 mm petri dishes 
with 2 X 2 mm grids etched in the bottom of the dish. 
Dishes were left undisturbed for ten days in a humidified 5% carbon 
dioxide, 37 C incubator. On day ten, growth of fibroblasts from the 
expiants was determined. Cells grown in gridded dishes were fixed with 
methanol and stained with giemsa. Number of grids containing fibroblasts 
was counted using an inverted light microscope. 
Cells grown in non-gridded dishes containing radiolabeled leucine had 
3-H-thymidine (approximately 160,000 dpm/dish, 89 mCi/mmol specific 
activity), added one hour prior to harvest for estimation of DNA synthesis. 
Radioactive medium was removed and plates were rinsed with nonradioactive 
medium. To dissolve the cells, 1 mL of 3 N NaOH was added and incubated 
for one hour at room temperature. Dissolved cells from the dish were 
placed in a glass scintillation vial. The dish was rinsed with 1 mL 
deionized water and .5 mL 6 N HCl to bring pH of dissolved cells in the 
vial to near neutral. Universol ES was added to the vial for liquid 
scintillation counting. Thymidine and leucine incorporation were measured 
as disintegrations per minute (dpm) per dish. Data on incorporation were 
normalized by calculating radioactivity incorporated as a percent of that 
added to the dishes. 
The first four tables represent data collected from individual young 
animals with averages determined for groups, separated on basis of sex. 
Tables are arranged to include animal identification number, birth and 
later weights (3 mo, 5 mo, 6 mo, 7 mo, 8 mo or 11 mo), % thymidine 
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incorporation (THY), % leucine incorporation (LEU) and number of 2 x 2 mm 
squares containing fibroblasts (plate count, PLT CT). 
The fifth table represents data from the cows. These animals were 
from the breeding herd. All animals were over two years of age. Animals 
were not weighed at time of sampling. 
The sixth table contains correlation coefficients from multiple 
regression equations relating cell culture data and birth weight with 
animal weight and from linear regression equations relating birth weight to 
animal weight. Multiple regression equations were calculated using THY, 
LEU, PLT CT and birth weight (BIR WT, kg) as the independent variables and 
actual animal weight (WT, kg) at 3, 5, 6, 7, 8 or 11 mo as the dependent 
variable. Linear regression values were obtained by using BIR WT (kg) as 
the independent variable and WT (kg) as the dependent variable. Table 7 
contains the multiple and linear regression coefficients for the regression 
equations. 
To examine effect of age on THY, LEU or PLT CT, data were grouped 
according to age, with data from different sexes and breeds pooled. The 
age groups were 1, 3, 5, 7, 8 mo and greater than 24 mo. 
Statistical Analysis 
Data were analyzed by analysis of variance using General Linear 
Models or Regression procedures of SAS (SAS, 1989). Least squares means at 
the different ages were separated on the basis of least significant 
differences using the predicted difference option (SAS, 1989). 
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RESULTS 
Cell culture data from Group I are shown in Table 1. THY values 
ranged from .85 to 2.11%, LEU from 6.51 to 15.13% and PLT CT 8.3 to 13.7, 
when these animals were approximately 3 mo. 
The results from Group II are given in Table 2. THY values ranged 
from 1.31 to 4.95%, .53 to 1.35%; LEU values ranged from 5.27 to 15.44%, 
1.35 to 4.39%; PLT CT values ranged from 9.7 to 18.7 and 0.0 to 13.3 at 1 
mo and 5 mo, respectively. 
Table 3 contains the results for Group III. THY values ranged from 
.66 to 2.19%, LEU from .4 to 2.85% and PLT CT from 3.5 to 11.5 at 8 mo. 
The results from Group IV are given in Table 4. THY ranged from .49 
to 1.69%, LEU from 1.61 to 3.27% and PLT CT from 6.0 to 14.0. 
The average THY, LEU and PLT CT for Group V are shown in Table 5. 
THY ranged from .85% to 1.74% and LEU from 3.44 to 10.05% for the animals 
exceeding 24 mo. PLT CT was lower than those from the younger animals 
shown in the preceding tables, with a range of 1.0 to 7.0. 
The correlation coefficients resulting from the multiple regression 
equations are shown in Table 6. Including cell culture data with birth 
weight improved the fit of the model, using cell culture data from 3 mo old 
animals and birth weight, to predict 6 mo weight of Group I heifers. Birth 
weight alone was not a good model for predicting 6 mo heifer weight and was 
not significant (P < .1). However for Group I bull calves, birth weight 
(P < .05) was a good model to predict 6 mo weight. Including cell culture 
data with birth weight was not significant (P < .1). For Group III Angus 
bulls, cell culture data from 8 mo old animals with birth weight was a good 
model for predicting 8 mo weight (P < .05). For Group IV, birth weight was 
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a good model for animal performance at both 7 and 11 mo (P < .05). The use 
of cell culture data with birth weight also provided a good model (P < .05) 
for predicting the performance of Group IV animals at 7 and 11 mo. In 
Group II, neither birth weight nor birth weight with cell culture data were 
good models for predicting animal weight at a future point in time. 
Table 7 contains linear and multiple regression equation coefficients 
for the various groups of cattle. There were very different coefficients 
resulting for the regression equations. 
Figure 1 represents the average THY and LEU for animals ranging in 
age from birth to maturity. Average THY was highest at 1 mo, decreased at 
5 mo and increased slightly at 8 mo for the calves. The average THY for 
cows was not different from 3 to 8 mo calves. Average LEU increased from 
birth to 3 mo, and then leveled off between 5 and 8 mo. Cows had an 
increased LEU, but not as high as calves at 1 or 3 mo. 
Figure 2 depicts PLT CT for the different ages. Calves at 1 mo of 
age exhibited the greatest average PLT CT. The extent of outgrowth of 
cells from the expiants decreased as the animals aged. 
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Table 1. Group I, Angus bulls and heifers sampled at 3 mo to determine 
growth from the tissue expiant and thymidine and leucine 
incorporation* 
ID BIR WT 3 MO 6 MO PLT THY LEU 
WT WT 
No SEX kg kg kg CT % % 
A945 B 45.5 143.6 299.5 10.7 1.14 8.53 
A947 B 44.5 142.7 299.5 10.7 1.67 10.51 
A948 B 40.0 126.4 293.6 11.3 1.60 11.43 
A943 B 43.6 124.5 291.4 9.3 1.36 10.66 
A938 B 36.4 105.5 282.7 11.7 1.20 7.08 
A941 B 40.9 130.0 275.9 8.3 1.78 8.58 
A942 B 33.6 101.8 266.4 12.3 2.11 16.13 
AVG 40.7 124.9 287.0 10.6 1.55 10.42 
A940 H 35.5 131.8 310.9 9.0 1.77 9.73 
A950 H 37.3 115.5 299.5 13.7 1.97 10.42 
A951 H 36.4 104.5 294.1 8.3 1.46 11.47 
A937 H 29.1 120.0 280.5 13.0 1.14 10.34 
A944 H 35.5 95.5 261.4 12.7 1.51 11.14 
A939 H 27.3 87.3 250.9 9.3 0.85 6.51 
A949 H 34.5 85.5 239.5 11.7 1.31 7.70 
AVG 33.6 105.7 276.7 11.1 1.43 9.62 
*ID No is the animal ear tag number; Sex: B represents bull, H 
represents heifer; animals were weighed at 3 and 6 mo; PLT CT: number of 
squares containing cells; THY: % thymidine incorporation; and LEU: % 
leucine incorporation. 
72 
Table 2a. Group II crossbred bulls sampled at 1 and 5 mo to determine 
growth from the tissue expiant and thymidine and leucine 
incorporation* 
1 Mo Sample 5 Mo Sample 
ID BIR PLT THY LEU PLT THY LEU 5 MO 7 MO 11 MO 
WT WT WT 
No WT CT % % CT % % kg kg kg 
29 47.3 12.0 2.23 5.27 10.0 1.35 4.39 240.0 298.6 409.1 
15 44.5 15.5 2.75 9.49 13.3 0.61 3.03 230.9 297.7 436.8 
3 39.1 13.0 2.93 7.58 0.0 0.69 2.57 237.3 291.4 411.8 
25 40.9 14.7 2.75 9.27 6.3 0.64 2.74 236.8 288.2 416.8 
6 45.5 10.3 2.89 8.02 5.7 0.63 3.09 233.6 280.9 394.5 
32 41.8 15.0 4.14 12.76 6.7 0.53 2.20 223.6 274.5 392.7 
9 38.2 11.0 3.20 10.34 8.3 1.07 4.21 225.5 265.9 376.8 
13 38.2 18.3 4.47 5.28 7.7 1.18 2.39 221.8 263.6 374.1 
26 36.4 13.7 4.95 12.11 13.0 0.53 2.51 210.0 262.7 385.0 
5 39.1 9.7 1.31 8.48 6.0 1.22 3.04 218.2 255.9 411.8 
2 41.8 16.0 2.76 7.19 1.0 0.56 1.35 200.0 233.6 350.5 
4 44.5 11.3 3.10 9.25 11.3 1.06 3.50 200.9 231.4 336.8 
1 40.0 10.3 3.46 6.29 8.3 0.83 2.99 200.0 215.9 349.5 
11 38.2 13.0 1.57 15.44 11.7 0.92 3.44 176.4 206.4 344.5 
AVG 41.1 13.1 3.04 9.05 7.8 0.84 2.96 218.2 261.9 385.1 
*ID No is the animal ear tag number; animals were weighed at 5, 7 and 
11 mo; PLT CT: number of squares containing cells; THY: % thymidine 
incorporation; and LEU: % leucine incorporation. 
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Table 2b. Group II crossbred heifers sampled at 1 and 5 mo of age to 
determine growth from the tissue expiant and thymidine and 
leucine incorporation* 
1 Mo Sample 5 Mo Sample 
ID BIR PLT THY LEU PLT THY LEU 5 MO 
WT 
7 MO 
WT 
11 MO 
WT 
No WT CT % % CT % % kg kg kg 
21 46.4 14.7 2.51 8.66 8.0 0.55 2.36 230.0 296.4 404.1 
35 35.5 12.0 2.48 9.45 7.0 0.74 3.14 197.3 257.3 354.5 
18 45.5 17.0 4.82 14.17 11.7 0.84 3.18 202.3 253.6 345.9 
10 35.5 10.3 3.82 11.45 8.0 1.23 3.80 193.6 246.4 340.0 
23 41.8 16.0 2.58 7.50 10.3 0.59 2.19 200.5 240.9 354.1 
20 40.9 14.0 3.02 10.49 8.3 0.68 1.65 198.6 235.5 351.8 
41 37.3 16.7 3.97 9.63 8.3 0.72 3.79 172.3 226.4 313.6 
31 40.9 13.7 2.76 6.03 11.3 0.82 3.27 185.5 222.3 348.6 
7 45.5 13.7 2.95 7.72 9.3 1.14 4.07 178.2 206.4 350.0 
16 37.3 9.7 4.74 14.22 6.7 0.78 3.17 179.1 205.0 300.5 
37 49.1 13.0 2.38 8.74 8.7 0.93 3.75 160.9 194.5 306.4 
40 36.4 18.7 3.76 8.63 6.3 0.74 3.10 151.8 184.5 317.3 
AVG 41.0 14.1 3.32 9.72 8.7 0.81 3.12 187.5 230.7 340.6 
*ID No is the animal ear tag number; animals were weighed at 5, 7 and 
11 mo; PLT CT: number of squares containing cells; THY: % thymidine 
incorporation; and LEU: % leucine incorporation. 
74 
Table 3. Group III, Angus (A) and Simmental (Y) bulls sampled at 8 mo of 
age to determine thymidine and leucine incorporation and growth 
from the tissue expiant* 
ID BIR WT THY LEU PLATE 8 MO WT 
No kg % % CT kg 
A912 44.6 1.65 0.54 8.5 374.6 
A902 45.4 1.67 2.34 11.5 358.2 
A914 40.9 1.36 2.32 11.0 329.1 
A918 34.6 0.98 1.97 9.0 328.2 
A927 44.6 2.19 2.55 6.7 322.7 
A928 40.9 1.42 2.16 8.7 319.1 
A911 37.3 0.66 1.45 8.5 315.4 
A917 43.2 1.46 2.01 8.0 314.6 
A924 41.8 1.10 2.41 8.5 310.0 
AVG 41.5 1.39 1.97 8.9 330.2 
Y903 50.0 1.70 1.75 5.3 385.4 
Y928 48.2 2.12 2.23 4.0 362.7 
Y905 42.7 1.14 2.17 10.5 353.6 
Y925 46.4 1.00 0.40 3.5 345.4 
Y926 47.3 1.23 2.20 8.5 344.6 
Y920 45.4 1.67 2.32 6.7 341.8 
Y927 44.6 1.36 2.85 7.5 324.6 
Y924 50.0 1.33 1.36 7.3 323.6 
Y909 40.0 1.23 1.89 8.5 313.6 
AVG 46.1 1.42 1.91 6.9 343.9 
*ID No is the animal ear tag number; animals were weighed at 8 mo; PLT 
CT: number of squares containing cells; THY: % thymidine incorporation; 
and LEU: % leucine incorporation. 
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Table 4. Group IV, crossbred heifers and steers sampled at 7 mo to 
determine thymidine and leucine incorporation and growth from the 
tissue expiant* 
ID SEX BIR WT THY LEU PLT 7 MO WT 11 MO WT 
No kg % % CT kg kg 
929 H 45.4 0.82 2.94 9.5 278.2 389.1 
915 H 43.6 1.23 2.04 6.0 258.2 365.9 
926 H 37.3 1.45 1.61 10.5 258.2 362.3 
919 H 39.1 1.36 2.87 7.0 237.7 348.2 
911 H 37.3 0.76 2.77 9.5 224.6 331.8 
922 H 30.9 1.02 2.91 7.0 207.3 308.2 
AVG H 38.9 1.11 2.52 8.2 244.0 350.9 
923 S 47.3 1.69 2.65 14.0 299.6 409.6 
912 S 45.9 0.89 3.27 7.0 293.2 402.3 
908 S 45.4 1.38 2.98 7.0 281.8 398.2 
939 S 46.4 1.67 2.87 7.5 277.7 380.4 
920 S 36.4 1.17 2.58 10.0 276.4 379.6 
921 S 39.1 1.06 2.26 9.5 271.4 383.2 
917 S 44.6 0.49 2.11 8.5 268.6 403.6 
916 S 40.9 0.59 2.10 5.0 266.8 382.7 
925 S 32.7 1.27 2.93 12.0 264.6 367.3 
930 S 30.0 1.54 2.38 6.0 224.6 315.4 
924 S 37.3 1.51 2.24 9.0 221.4 313.6 
AVG S 40.5 1.21 2.58 8.7 267.8 376.0 
*ID No is the animal ear tag number; Sex: H for heifer and S for 
steer; animals were weighed at 7 and 11 mo; PLT CT: number of squares 
containing cells; THY: % thymidine incorporation; and LEU: % leucine 
incorporation. 
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Table 5. Group V, Angus cows sampled at ages exceeding 24 mo to determine 
growth from the tissue expiant and thymidine and leucine 
incorporation* 
ID PLT THY LEU 
No CT % % 
106 5.7 1.55 10.04 
118 6.3 1.23 6.98 
217 7.0 1.35 4.99 
223 1.0 1.17 6.23 
319 5.0 1.14 5.68 
346 3.7 0.92 4.07 
408 6.3 1.36 10.00 
415 2.7 0.85 3.44 
423 4.3 1.74 10.05 
542 3.0 0.87 5.46 
610 5.0 1.12 4.48 
821 6.7 1.21 8.58 
AVG 4.7 1.21 6.67 
*ID No is the animal ear tag number; PLT CT: number of squares 
containing cells; THY: % thymidine incorporation; and LEU: % leucine 
incorporation. 
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Table 6. Correlation coefficients for multiple regression equations using 
birth weight with cell culture data and correlation coefficients 
for linear regression equations using birth weight to predict 
animal weight at different ages^ 
Age Age at Mult. BIR 
at Pred. Reg. WT 
Group n Breed Sex Sampling WT r2 r2 
I 7 A B 3 3 .97* .58* 
3 6 .94 .64** 
7 A H 3 3 .87 .06 
3 6 .96* .20 
II 14 C*S B 1 7 .22 .13 
1 11 .08 .05 
5 5 .28 .13 
5 11 .10 .05 
12 C*S H 1 7 .25 .01 
1 11 .30 .08 
5 5 .37 .04 
5 11 .33 .08 
III 9 A B 8 8 .91** .19 
9 S B 8 8 .38 .28 
IV 11 C*S S 7 7 .80** .54** 
7 11 .84** .59** 
6 C*S H 7 7 .93 .79** 
7 11 .96 .84** 
*Breed: Angus (A), Charolais (C), Simmental (S); Sex: bull (B) and 
heifer (H); Age at Sampling: mo of age at sampling time; Pred. Wt. Age: 
age of animal when weight was being predicted; Mult. Reg. r^: correlation 
coefficient resulting from the multiple regression equation using cell 
measurements and birth wt; and BIR WT r': linear regression correlation 
coefficient for birth weight used to predict weight of animals. 
**P < .05, *P < .1. 
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Table 7. Coefficients for linear regression equations using birth 
weight or multiple regression equations using birth 
weight and cell culture data to predict animal weight* 
BIR 
Group Sex TIME Inter. PL CT THY LEU WT 
I B birth - 3 mo 71.07 1.50 
3 mo - 3 mo 122.93 -2.71 -6.14 -1.81 1.65 
birth - 6 mo 238.05 1.33 
3 mo - 6 mo 274.83 -1.81 -4.19 -1.40 1.44 
I H birth - 3 mo 69.90 1.06 
3 mo - 3 mo 220.44 -2.98 82.34 4.96 -7.35 
birth - 6 mo 171.89 3.12 
3 mo - 6 mo 403.55 -6.68 113.05 8.04 -8.67 
II B birth - 5 mo 134.25 2.04 
5 mo - 5 mo 148.56 -2.07 -13.67 10.13 1.64 
5 mo - 11 mo 322.91 -1.34 -32.31 12.15 1.56 
birth - 7 mo 127.10 3.28 
birth - 7 mo 95.69 2.04 4.05 -1.42 3.41 
birth - 11 mo 301.62 2.03 
birth - 11 mo 317.74 2.16 -4.94 -0.99 1.53 
H birth - 5 mo 152.06 0.86 
5 mo - 5 mo 199.95 2.80 13.08 -18.20 0.23 
5 mo - 11 mo 326.32 2.53 18.04 -21.86 1.12 
birth - 7 mo 205.06 0.63 
birth - 7 mo 220.68 3.21 -36.29 12.09 -0.79 
birth - 11 mo 269.98 1.72 
birth - 11 mo 333.18 2.53 -26.32 4.83 0.29 
*The linear regression equations are represented by birth - (3, 5, 6, 
7 or 11 mo) to represent birth weight being used to predict 3, 5, 6, 7 or 
11 mo weight, respectively, in the TIME column. The TIME column also 
represents the multiple regression equations using birth weight and cell 
culture data (THY, LEU, PLT CT and BIR WT) to predict weights at the time 
of sampling or later weights. 
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Table 7. Continued. 
BIR 
Group Sex TIME Inter. PL CT THY LEU • WT 
III B birth - 8 mo 221.09 2.63 
8 mo - 8 mo 287.15 9.07 37.46 -27.26 -0.87 
birth - 8 mo 182.73 3.50 
8 mo - 8 mo 210.27 0.91 30.30 -6.84 2.12 
IV S birth - 7 mo 143.94 3.06 
7 mo - 7 mo 99.64 3.44 -21.91 27.01 2.34 
birth - 11 mo 202.64 4.28 
7 mo - 11 mo 187.73 4.41 -42.16 23.21 3.48 
H birth - 7 mo 72.69 4.40 
7 mo - 7 mo 24.85 4.33 19.25 -3.49 4.39 
birth - 11 mo 155.65 5.01 
7 mo - 11 mo 83.02 4.77 25.09 1.23 5.08 
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Figure 1. Alteration in percent incorporation of thymidine and leucine of bovine fibroblasts as donors 
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Figure 2. Alteration in outgrowth of bovine fibroblasts from tissue expiants as donors age increased 
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DISCUSSION 
The cell measurements and BIR WT or BIR WT alone were not consistent 
for predicting future animal performance in the different groups. The cell 
measurements and BIR WT resulted in high r^ values indicating that multiple 
regression was a good model for these data. However, due to the small 
number of animals sampled, the r^ values were not significant for the 
majority of the animals because of a lack of power for the statistical 
test. The predictive ability of the cell culture data with BIR WT was not 
dependent on breed or sex of the cattle. 
Cells from calves, less than 1 mo, exhibited higher rates of THY than 
did older calves. If bovine fibroblasts do not increase cell DNA content 
with age, then young calves may have more cells traversing the cell cycle 
and fewer non-cycling cells or the cells may be proceeding through the cell 
cycle at a faster rate than cells from an older animal. DNA content of 
human fibroblasts did not change as a function of rn vitro ageing and was 
not significantly affected by donor age (Schneider and Mitsui, 1976) and 
there was an increased number of non-cycling cells as donor age increased 
(Hasawaga et al., 1985). 
Fibroblasts from young calves had the highest LEU indicating cells 
from calves were synthesizing more protein. Young calves are growing 
muscle tissue with very little adipose tissue being deposited. The 
increased leucine incorporation in the cows was unexpected and unexplained. 
These cows were pregnant, either late second trimester or early third 
trimester, which might have influenced LEU. 
There was a linear relationship between animal age and PLT CT. 
Calves less than 1 mo of age had the highest growth rate relative to body 
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weight and the highest PLT CT. Mature cows had the lowest growth rate 
relative to body weight and the lowest PLT CT. This was similar to 
findings of Goldstein (1974) using skin from the base of the neck of 
juvenile and adult Galapagos turtles. The first appearance of fibroblasts 
from the young turtle primary expiants occurred earlier than from older 
turtles. Cultured fibroblasts from young turtles incorporated more 
thymidine than did cells from older turtles. Conclusions were made that 
expiants from older animals have a longer latent time prior to outgrowth 
and that outgrowth is less vigorous and from a smaller proportion of the 
tissue fragments in the older animals. An inverse relationship has been 
shown to exist between human donor age and the number of times cells may be 
subcultured prior to senescence, when cells no longer grow (Hayflick, 1965; 
Ohno, 1979; Phillips et al., 1984). 
Young animals have rapid increase in body size that decreases as 
maturity is reached. Skeletal muscle growth in calves (110 to 360 kg) 
results from an increase in cellularity (number of nuclei per muscle fiber) 
and from an increase in cell size (Trenkle et al., 1978). In cattle 
exceeding 360 kg, muscle growth resulted from an increase in cell size. 
The measured cell parameters of bovine fibroblasts of dermal origin changed 
with age, suggesting that cultured fibroblasts retain the growth pattern of 
the donor animal. As maturity is reached, the animal enters a maintenance 
situation where body size remains fairly constant. 
There was a wide range of variation in the values within animals in 
an age group and an overlap of values among age groups, indicating a large 
amount of variation in cells from different donors. Age of animals sampled 
ranged from a few days to over 10 years. 
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These results indicate that the potential for animal growth was 
expressed in cultured fibroblasts but the measurements of growth of the 
cells in culture did not always predict live weight at a future point in 
time. The use of cell culture data with birth weight provided a good model 
to predict weights of some groups but not for others. 
There may be a specific protein, possibly a growth factor or enzyme, 
that would be more indicative of animal performance at a future point than 
measuring leucine incorporation by fibroblasts. If this protein is 
synthesized by fibroblasts, determination of the amount of this protein 
present in the cell culture will provide additional information for the 
beef producer to select animals that produce lean beef efficiently. 
85 
CONCLUSIONS 
Cell culture data with birth weight provided a useful model to 
predict animal performance for some groups of cattle. In some cases, the 
high correlation coefficients for the multiple regression equations, using 
cell culture data and birth weight, were not significant due to the small 
numbers of animals sampled. A large group of young animals maintained in a 
similar environment need to be sampled at one time to help determine if 
cell cultures are indicative of future animal performance. 
There was a linear relationship between outgrowth of cells from the 
expiant and age of the animal. Fibroblast growth was greatest in expiants 
from young calves and their growth occurs by increasing cellularity and 
cell size; whereas, growth in older animals occurs by increasing cell size. 
It appears that cultured fibroblasts may retain the ability to grow in a 
similar manner as the donor animal. 
86 
SECTION IV. 
COMPARISON OF GROWTH OF PORCINE FIBROBLASTS 
IN CULTURE WITH GROWTH OF DONOR ANIMALS 
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INTRODUCTION 
Animal growth as measured by weight gain may represent an increase in 
cell number, an increase in cell size or a combination of these. Muscle 
DNA and RNA content and concentrations have been measured to determine if 
these are indicative of protein synthesis and lean muscle mass of the 
animal (Harbison et al., 1976). Blood concentrations of hormones (Trenkle 
and Topel, 1978; Verde and Trenkle, 1987; and Plouzek and Trenkle, 1991a) 
and growth factors (Plouzek and Trenkle, 1991b) have been related to animal 
growth. The next development was obtaining tissue biopsies for determining 
mRNA levels (Hannon et al., 1991) or cul taring cells to study the effects 
on growth of hormones and growth factors in isolated cells. 
During attempts to establish bovine cell cultures, an observation was 
made that the rate of fibroblast growth from tissue expiants appeared to be 
related to donor animal growth. To determine if such a relationship 
exists, pigs were chosen for comparison of growth rate of fibroblasts in 
culture with growth rate of donor animals. 
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MATERIALS AND METHODS 
Materials 
Materials were purchased from the following sources: Ham's F-12 
powdered medium, penicillin, streptomycin sulfate, nystatin and giemsa from 
Sigma Chemical Company (St. Louis, MO); leucine (14-C) and thymidine (3-H) 
from Amersham International (Amersham, UK); fetal bovine serum (FBS) from 
Gibco Laboratories (Grand Island, NY); Universol ES from ICN Biochemicals. 
Inc. (Irvine, CA); petri dishes from Nunc (Roskilde, Denmark); Stadie-Riggs 
Microtome from Thomas Scientific (Swedesboro, NJ); glass coverslips and 
methanol from Fisher Scientific (Chicago, IL); and high vacuum grease from 
Dow Corning (Midland, MI). 
Methods 
Twelve litters of pigs from the Iowa State University Swine Teaching 
Farm were utilized in this study. There were approximately 100 animals 
sampled; however, data from 83 animals were used in this study. Data from 
animals that died during the study were deleted. Animals were sampled at 
near birth, approximately twenty-one days (21 d) and five months of age 
(5 mo). 
A sample of skin was taken from an ear via punch biopsy using an ear 
notcher and plated in duplicate or triplicate as described in Section III, 
with radiolabeled 14-C-leucine (65,000 dpm/dish, 57 mCi/mmol specific 
activity) added at time of plating to the culture medium to estimate 
protein synthesis. Radiolabeled 3-H-thymidine (180,000 dpm/dish, 89 
mCi/mmol specific activity) was added one hour prior to harvest for 
estimation of DMA synthesis. Thymidine and leucine incorporation were 
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measured as disintegrations per minute per dish. Data on incorporation 
were normalized by calculating radioactivity incorporated as a percent of 
that added to the dish. 
The first three tables represent averages of data collected from 
groups of animals, separated on the basis of sex. Tables are arranged to 
include number of animals per group, weight at time of sampling, percent 
thymidine incorporation (THY), percent leucine incorporation (LEU) and 
number of 2 x 2 mm squares containing fibroblasts (plate count, PLT CT). 
The correlation coefficients for the multiple regression equations 
calculated from the cell culture measurements are given in the fourth 
table. Multiple regression equations were calculated using THY, LEU and 
PLT CT as the independent variables and animal weight at birth, 21 d or 5 
mo as the dependent variable. Cell culture data collected at birth were 
used to predict birth, 21 d or 5 mo weight. Twenty-one day cell culture 
data were used to predict 21 d weight or 5 mo weight. Five month cell 
culture data were used to predict 5 mo weight. 
The coefficients of the multiple regression equations are given in 
the fifth table, using THY, LEU and PLT CT as the independent variables and 
WT, at birth, 21 d or 5 mo, as the dependent variable. There was a wide 
range of values from the intercept and coefficients for THY, LEU and PLT 
CT. 
To examine differences related to age, data from different sexes and 
litters were pooled and sorted based on age: birth, 21 d and 5 mo. 
Statistical Analysis 
Data were analyzed by analysis of variance using the General Linear 
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Models and Regression procedures of SAS (SAS, 1989). Differences between 
least squares means at the different ages were separated on the basis of 
least significant differences using the predicted difference option (SAS, 
1989). 
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RESULTS 
The results from the samples taken at birth are given in Table 1. 
The animals were separated into groups based on sex: boars, barrows 
(castrated at approximately three weeks of age) and gilts. The averages 
for the animals at birth are: 2,2 to 2.5 kg body weight, .86 to .93% THY, 
6.39 to 8.34% LEU and 12.8 to 13.5 PLT CT. Averages and ranges in values 
for animals separated into groups on the basis of sex are shown. 
The results from samples taken at 21 d are given in Table 2. The 
increased number of animals reflects the addition of cell culture data from 
three litters that were lost due to failure of the incubator. The averages 
for the animals are: 6.8 to 7.0 kg body weight, 1.17 to 1.28% THY, 8.84 to 
11.53% LEU and 9.3 to 10.8 PLT CT. The averages and range in values for 
the three groups of animals separated by sex are given. 
The results from samples taken at 5 mo are given in Table 3. The 
averages for the animals are: 90.4 to 99.3 kg body weight, 1.08 to 1.17% 
THY, 6.15 to 6.59% LEU and 6.4 to 6.6 PLT CT. The averages and range in 
values for the three groups of animals separated by sex are given. 
Table 4 contains the correlation coefficients for predicting animal 
weight from the cell measurements. For boars, the cell culture data 
collected at birth used to predict birth weight resulted in a high r^ value 
(r^ = .73) indicating the model fit the data. However, due to the small 
number of animals sampled, this was not significant due to a lack of power 
of the statistical test. Similarly, using cell culture data from the birth 
sample was not statistically significant in predicting 21 d boar 
performance even thought there was a high r^ value (r^ = .79). Cell 
culture data collected at birth was statistically significant for 
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Table 1. Cell culture data from pig samples collected at birth to 
determine thymidine and leucine incorporation and growth from 
the tissue expiant* 
Wt THY LEU PLT CT 
SEX n kg % % No. 
Boars, avg 7 2.2 .90 6.39 13.5 
Range 1.5-3.6 .41-1.29 2.70-10.3 9.0-19.5 
Barrows, avg 29 2.6 .86 8.34 12.8 
Range .9-4.1 .32-1.70 1.59-14.86 3.0-19.0 
Gilts, avg 29 2.5 .93 7.90 13.8 
Range 1.1-5.0 .30-1.80 1.90-12.88 4.5-21.3 
*Average values for boars, barrows and gilts are given for weight at 
time of sampling, % thymidine and leucine incorporation by the expiants and 
plate count, average number of squares containing cells. The range in 
values for the groups are listed. 
Table 2. Cell culture data from samples collected at 21 d to determine 
thymidine and leucine incorporation and growth from the tissue 
expiant* 
Wt THY LEU PLT CT 
SEX n kg % % No. 
Boars, avg 8 6.9 1.17 8.84 9.3 
Range 3.4-11.1 .53-1.63 5. 50-11.43 6.0-13.0 
Barrows, avg 33 6.8 1.21 11.53 10.7 
Range 3.2-9.3 .69-2.14 2. 58-23.82 5.0-18.5 
Gilts, avg 42 7.0 1.28 9.40 10.8 
Range 3.0-13.2 .53-3.43 3. 10-17.90 1.0-20.5 
•Average values for boars, barrows and gilts are given for weight at 
time of sampling, % thymidine and leucine incorporation by the expiants and 
plate count, average number of squares containing cells. The range in 
values for the groups are listed. 
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Table 3. Cell culture data from pig samples collected at 5 mo to determine 
thymidine and leucine incorporation and growth of cells from the 
tissue expiant* 
Wt THY LEU PLT CT 
SEX n kg % % No. 
Boars, avg 8 99.2 1.17 6.21 6.5 
Range 82 .7-136.4 .43-1.94 2.48-8.74 3.0-11.3 
Barrows, avg 33 93.2 1.08 6.59 6.4 
Range 72 .7-122.7 .48-2.16 2.33-15.08 3.0-14.3 
Gilts, avg 42 90.4 1.12 6.15 6.6 
Range 62 .7-117.3 .22-2.09 1.45-12.56 0.0-11.0 
*Average values for boars, barrows and gilts are given for weight at 
time of sampling, % thymidine and leucine incorporation by the expiants and 
plate count, average number of squares containing cells. The range in 
values for the groups are listed. 
predicting boar performance at 5 mo (r^ = .89) as was 21 d cell culture 
data for predicting 21 d performance (r^ = .78). For the barrows and 
gilts, cell culture data were not a good model to predict animal 
performance. Table 5 contains the coefficients of the multiple regression 
equations for predicting animal performance for the three groups of animals 
separated on the basis of sex. 
Figure 1 represents the average THY and LEU for the pigs from birth 
to 5 mo. Average THY was lowest at birth and increased at 21 d. THY was 
not different between 21 d and 5 mo (P < .01). Average LEU increased from 
birth to 21 d and decreased at 5 mo (P < .01). 
Figure 2 depicts PLT CT for the three ages. Pig samples collected at 
birth exhibited the greatest growth from the expiant. The extent of cell 
growth from the expiant decreased as animals aged. 
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Table 4. Correlation coefficients for the multiple regression equations 
using cell culture data to predict animal weight at different 
ages* 
Age at Age at 
SEX n Sampling Pred. Wt r2 
Boars 7 birth birth 
C
O
 
7 birth 21 d .79 
7 birth 5 mo .89* 
8 21 d 21 d .78* 
8 21 d 5 mo .64 
8 5 mo 5 mo .71 
Barrows 29 birth birth .21 
29 birth 21 d .12 
29 birth 5 mo .18 
33 21 d 21 d .17 
33 21 d 5 mo .02 
33 5 mo 5 mo .37 
Gilts 29 birth birth .29 
29 birth 21 d .07 
29 birth 5 mo .08 
42 21 d 21 d .15 
42 21 d 5 mo .11 
42 5 mo 5 mo .11 
^Correlation coefficients for samples collected at birth to predict 
birth weight, 21 d weight or 5 mo weight; 21 d samples were used to predict 
21 d weight and 5 mo weight; and 5 mo cell culture data were used to 
predict 5 mo weight. 
*P < .1. 
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Table 5. Coefficients for the multiple regression equations using cell 
culture data to predict animal weight* 
Sample Age PLT 
Time WT Inter. THY LEU CT 
Boars 
birth birth 2.55 -0.80 0.12 -0.02 
birth 21 d 5.46 1.04 0.12 -0.06 
birth 5 mo 80.54 7.91 1.27 -0.33 
21 d 21 d 5.25 1.54 0.05 -0.09 
21 d 5 mo 92.18 2.64 0.07 -0.28 
5 mo 5 mo 118.03 -13.67 -0.97 -0.58 
Barrows 
birth birth 2.04 .62 0.16 -0.11 
birth 21 d 7.72 1.81 0.50 -0.43 
birth 5 mo 94.57 3.59 7.06 -3.29 
21 d 21 d 8.80 4.12 -0.83 0.07 
21 d 5 mo 138.94 21.87 -5.60 -1.70 
5 mo 5 mo 117.28 19.33 -6.28 -0.26 
Gilts 
birth birth 2.92 -1.08 0.12 -0.04 
birth 21 d 7.65 -0.17 0.03 -0.11 
birth 5 mo 80.09 0.41 1.26 0.06 
21 d 21 d 7.75 -0.45 0.13 -0.13 
21 d 5 mo 84.17 0.52 1.16 -0.50 
5 mo 5 mo 74.27 9.85 -0.16 0.92 
*Sample Time indicates when samples were collected and Age WT was the 
weight of the animal used as the dependent variable. 
14 -
12 -
Birth 
a,b,CBars with same stripes and different letters differ (P < .01). 
Figure 1. Alteration in percent incorporation of thymidine and leucine of porcine fibroblasts as donors 
age increased 
Birth 21 d 5 mo 
Age 
a,b,CBars with different letters differ (P < .01). 
Figure 2. Alteration in outgrowth of porcine fibroblasts from tissue expiants as donors age increased 
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DISCUSSION 
The cell measurements were not consistent in the ability to predict 
future animal performance in the different age and sex groups. The cell 
measurements resulted in high r^ values indicating that multiple regression 
was a good model for the boar data. However, due to the small number of 
boars sampled, the r^ values were not significant for the majority of the 
animals because of a lack of power for the statistical test. 
Cells from young pigs exhibited lower rates of THY than did cells 
from older pigs. If porcine fibroblasts do not increase cell DNA content 
with age, young pigs may have fewer cells traversing the cell cycle than 
cells from older pigs. DNA content of human fibroblasts did not change as 
a function of in vitro ageing and was not significantly affected by donor 
age (Schneider and Mitsui, 1976) and there was an increased number of non-
cycling cells as donor age increased (Hasawaga et al., 1985). 
Fibroblasts from pigs sampled at 21 d had the highest LEU, young pigs 
were synthesizing more protein than were 5 mo old animals. Young pigs are 
growing muscle tissue with very little adipose tissue being deposited; 
whereas, the 5 mo old animals are depositing both muscle and adipose 
tissues. 
There was a linear relationship between animal age and PIT CT. Pigs 
at birth had the highest growth rate relative to body weight and the 
highest PIT CT. This was similar to findings of Goldstein (1974) using 
skin from the base of the neck of juvenile and adult Galapagos turtles. 
The first appearance of fibroblasts from the young turtle primary expiants 
occurred earlier than from older turtles. Cultured fibroblasts from young 
turtles incorporated more thymidine than did cells from older turtles. 
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Conclusions were made that explants from older animals have a longer latent 
time prior to outgrowth and that outgrowth is less vigorous and from a 
smaller proportion of the tissue fragments in the older animals. An 
inverse relationship has been shown to exist between human donor age and 
the number of times cells may be subcultured prior to senescence, when 
cells no longer grow (Hayflick, 1965; Ohno, 1979; Phillips et al., 1984). 
Young animals exhibit rapid increases in body size early in life and 
have decreased rate of growth as maturity is reached. The measured cell 
parameters of porcine fibroblasts of dermal origin changed with age, 
suggesting that cultured fibroblasts retain the growth pattern of the donor 
animal. As maturity is reached, the animal enters a maintenance situation 
where body size remains fairly constant. 
There was a wide range of variation in the values within animals in 
an age group and an overlap of values among age groups, indicating a large 
amount of variation in cells from different donors. Age of animals sampled 
ranged from birth to five months. There were purebred spotted, duroc, and 
Yorkshire and crossbred animals included in this study. Some animals may 
reach maturity at lighter weights than others due to the differences in the 
genetic pool sampled. At the same age, animals could be at different 
points on their physiological growth curves. 
These results indicate that the potential for animal growth was 
expressed in cultured fibroblasts but the measurements of growth of the 
cells in culture did not always predict live weight at a future point in 
time. There may be a specific protein, possibly a growth factor or enzyme, 
that would be more indicative of animal performance at a future point than 
measuring leucine incorporation by fibroblasts. If this protein is 
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synthesized by fibroblasts, determination of the amount of this protein 
present in the cell culture will provide additional information for the 
pork producer to select animals that produce lean pork efficiently. 
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CONCLUSIONS 
The cell culture measurements used in this research were not good 
predictors of future animal weights. There was a linear relationship 
between age and outgrowth of fibroblasts from the expiant. Explants from 
younger pigs exhibited more fibroblast growth than was seen from expiants 
collected from animals at older ages. Because young animals have the 
highest growth relative to body weight, the greater growth of cells from 
expiants of young animals may be indicative of growth potential. 
Animals have the most rapid growth relative to body weight early in 
life. Thymidine incorporation increased as pigs aged from birth to 21 d 
and expiants from animals at 21 d incorporated more leucine than did 
samples from animals at birth or 5 mo. Following birth, most of this soft 
tissue growth early in life is muscle. It appears that cultured 
fibroblasts may retain the ability to grow in a similar manner as the donor 
animal. 
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GENERAL SUMMARY 
The research presented in this dissertation has utilized cells 
collected from farm animals. Much data have accumulated on the response of 
cultured fibroblasts, derived from humans or rodent tissue, to hormones and 
growth factors. 
In Section I, the methods used to collect and propagate bovine 
fibroblasts were identified. The ears of cattle and pigs provided a 
readily accessible site for biopsy. Skin samples were collected from 
animals of various sizes and from the same animal at different times and 
were propagated and subcultured. Cells collected and grown in this manner 
responded to the addition of serum to the medium by increasing thymidine 
and leucine incorporation. The response of bovine fibroblasts to hormones 
that are known to regulate animal growth was examined. Without serum, 
growth hormone, insulin or thyroxine did not affect DNA synthesis. The 
addition of dexamethasone or estradiol was inhibitory. Addition of insulin 
to medium containing one percent fetal bovine serum increased thymidine 
incorporation in two of four experiments. Dexamethasone inhibited 
thymidine incorporation in the presence of one percent serum, but not in 
ten percent serum. The inhibition of leucine incorporation by the presence 
of insulin was unexpected. Estradiol alone did not stimulate leucine 
incorporation in cultured bovine fibroblasts. Thyroxine given in the 
presence of one percent serum stimulated leucine incorporation but 
thyroxine was not stimulatory by itself. Thyroxine required the presence 
of some unidentified compound contained in serum to elicit an increase in 
leucine uptake. None of the hormones alone or in combination seemed to be 
potent regulators of fibroblast growth. 
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Bovine fibroblasts derived from dermal tissue responded to the 
addition of growth factors by increasing thymidine and leucine 
incorporation. Similar levels of IGF-I were required by bovine cells as in 
humans fibroblasts to stimulate a growth response. EGF also increased 
uptake of thymidine and leucine by bovine fibroblasts. Combinations of 
hormones and growth factors were not better than growth factors alone. The 
addition of ten percent serum stimulated more thymidine or leucine 
incorporation than any combination of hormone and growth factors used. 
The measurements on the growth of fibroblasts presented in Sections 
III and IV for predicting animal weight at a specific point in the future 
were not reliable or extremely accurate. The bovine or porcine fibroblasts 
from animals of different ages exhibited a wide variation in response to 
similar culture conditions. Outgrowth of fibroblasts from the expiants of 
bovine or porcine tissue decreased as animal age increased. This decrease 
in outgrowth from the expiant as animals age may be related to the decrease 
in growth rate relative to body weight as the animal approaches maturity. 
Fibroblasts were a useful model for measuring the effects of hormones 
or growth factors but measurements of thymidine incorporation, leucine 
incorporation and fibroblast growth from the expiants are not good 
predictors of animal growth. 
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